Cover Page
Cover Page - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Feb. 26, 2024 | Jun. 30, 2023 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2023 | ||
Current Fiscal Year End Date | --12-31 | ||
Document Transition Report | false | ||
Entity File Number | 001-13337 | ||
Entity Registrant Name | STONERIDGE INC | ||
Entity Incorporation, State or Country Code | OH | ||
Entity Tax Identification Number | 34-1598949 | ||
Entity Address, Address Line One | 39675 MacKenzie Drive, Suite 400 | ||
Entity Address, City or Town | Novi | ||
Entity Address, State or Province | MI | ||
Entity Address, Postal Zip Code | 48377 | ||
City Area Code | 248 | ||
Local Phone Number | 489-9300 | ||
Title of 12(g) Security | Common Shares, without par value | ||
Trading Symbol | SRI | ||
Security Exchange Name | NYSE | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Document Financial Statement Error Correction [Flag] | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 504.3 | ||
Entity Common Stock, Shares Outstanding | 27,553,610 | ||
Documents Incorporated by Reference | Definitive Proxy Statement for the Annual Meeting of Shareholders to be held on May 14, 2024, into Part III, Items 10, 11, 12, 13 and 14. | ||
Entity Central Index Key | 0001043337 | ||
Document Fiscal Year Focus | 2023 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false |
Audit Information
Audit Information | 12 Months Ended |
Dec. 31, 2023 | |
Audit Information [Abstract] | |
Auditor Name | Ernst & Young LLP |
Auditor Location | Detroit, MI |
Auditor Firm ID | 42 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Current assets: | ||
Cash and cash equivalents | $ 40,841 | $ 54,798 |
Accounts receivable, less reserves of $1,058 and $962, respectively | 166,545 | 158,155 |
Inventories, net | 187,758 | 152,580 |
Prepaid expenses and other current assets | 34,246 | 44,018 |
Total current assets | 429,390 | 409,551 |
Long-term assets: | ||
Property, plant and equipment, net | 110,126 | 104,643 |
Intangible assets, net | 47,314 | 45,508 |
Goodwill | 35,295 | 34,225 |
Operating lease right-of-use asset | 10,795 | 13,762 |
Investments and other long-term assets, net | 46,980 | 44,416 |
Total long-term assets | 250,510 | 242,554 |
Total assets | 679,900 | 652,105 |
Current liabilities: | ||
Current portion of debt | 2,113 | 1,450 |
Accounts payable | 111,925 | 110,202 |
Accrued expenses and other current liabilities | 64,203 | 66,040 |
Total current liabilities | 178,241 | 177,692 |
Long-term liabilities: | ||
Revolving credit facility | 189,346 | 167,802 |
Deferred income taxes | 7,224 | 8,498 |
Operating lease long-term liability | 7,684 | 10,594 |
Other long-term liabilities | 9,688 | 6,577 |
Total long-term liabilities | 213,942 | 193,471 |
Shareholders' equity: | ||
Preferred Shares, without par value, 5,000 shares authorized, none issued | 0 | 0 |
Common Shares, without par value, 60,000 shares authorized, 28,966 and 28,966 shares issued and 27,549 and 27,341 shares outstanding at December 31, 2023 and December 31, 2022, respectively, with no stated value | 0 | 0 |
Additional paid-in capital | 227,340 | 232,758 |
Common Shares held in treasury, 1,417 and 1,625 shares at December 31, 2023 and December 31, 2022, respectively, at cost | (43,344) | (50,366) |
Retained earnings | 196,509 | 201,692 |
Accumulated other comprehensive loss | (92,788) | (103,142) |
Total shareholders' equity | 287,717 | 280,942 |
Total liabilities and shareholders' equity | $ 679,900 | $ 652,105 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Accounts receivable, reserves | $ 1,058 | $ 962 |
Preferred shares, authorized (in shares) | 5,000,000 | 5,000,000 |
Preferred shares, issued (in shares) | 0 | 0 |
Common shares, authorized (in shares) | 60,000,000 | 60,000,000 |
Common shares, issued (in shares) | 28,966,000 | 28,966,000 |
Common shares, outstanding (in shares) | 27,549,000 | 27,341,000 |
Common shares held in treasury, shares (in shares) | 1,417,000 | 1,625,000 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement [Abstract] | |||
Net sales | $ 975,818 | $ 899,923 | $ 770,462 |
Costs and expenses: | |||
Cost of goods sold | 774,512 | 724,997 | 603,604 |
Selling, general and administrative | 117,395 | 106,695 | 116,000 |
Gain on sale of Canton Facility, net | 0 | 0 | (30,718) |
Design and development | 71,075 | 65,296 | 66,165 |
Operating income | 12,836 | 2,935 | 15,411 |
Interest expense, net | 13,000 | 7,097 | 5,189 |
Equity in loss (earnings) of investee | 522 | 823 | (3,658) |
Other expense, net | 1,236 | 5,711 | 1,444 |
(Loss) income before income taxes | (1,922) | (10,696) | 12,436 |
Provision for income taxes | 3,261 | 3,360 | 9,030 |
Net (loss) income | $ (5,183) | $ (14,056) | $ 3,406 |
(Loss) earnings per share: | |||
Basic (in dollars per share) | $ (0.19) | $ (0.52) | $ 0.13 |
Diluted (in dollars per share) | $ (0.19) | $ (0.52) | $ 0.12 |
Weighted-average shares outstanding: | |||
Basic (in shares) | 27,442,984 | 27,258,456 | 27,114,359 |
Diluted (in shares) | 27,442,984 | 27,258,456 | 27,415,534 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands | 12 Months Ended | |||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | ||
Statement of Comprehensive Income [Abstract] | ||||
Net (loss) income | $ (5,183) | $ (14,056) | $ 3,406 | |
Other comprehensive income (loss), net of tax: | ||||
Foreign currency translation | [1] | 9,118 | (6,171) | (8,408) |
Unrealized gain on derivatives | [2] | 1,236 | 53 | 1,019 |
Other comprehensive income (loss), net of tax | 10,354 | (6,118) | (7,389) | |
Comprehensive income (loss) | $ 5,171 | $ (20,174) | $ (3,983) | |
[1] Net of tax expense of $514 and $267 for the years ended December 31, 2022 and 2021, respectively. Net of tax expense of $328, $14 and $271 for the years ended December 31, 2023, 2022 and 2021, respectively. |
CONSOLIDATED STATEMENTS OF CO_2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Statement of Comprehensive Income [Abstract] | |||
Tax expense on foreign currency translation | $ 514 | $ 267 | |
Tax expense on unrealized gain on derivatives | $ 328 | $ 14 | $ 271 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
OPERATING ACTIVITIES: | |||
Net (loss) income | $ (5,183) | $ (14,056) | $ 3,406 |
Adjustments to reconcile net income to net cash provided by (used for) operating activities: | |||
Depreciation | 26,749 | 26,720 | 27,823 |
Amortization, including accretion and write-off of deferred financing costs | 8,132 | 8,055 | 6,648 |
Deferred income taxes | (4,038) | (5,110) | (511) |
Loss (earnings) of equity method investee | 522 | 823 | (3,658) |
Gain on sale of fixed assets | (860) | (241) | (165) |
Share-based compensation expense | 3,322 | 5,942 | 5,960 |
Excess tax deficiency (benefit) related to share-based compensation expense | 230 | 543 | (563) |
Gain on sale of Canton Facility, net | 0 | 0 | (30,718) |
Gain on disposal of business and joint venture, net | 0 | 0 | (2,942) |
Change in fair value of earn-out contingent consideration | 0 | 0 | 2,065 |
Changes in operating assets and liabilities: | |||
Accounts receivable, net | (5,854) | (13,161) | (17,019) |
Inventories, net | (31,563) | (20,127) | (51,270) |
Prepaid expenses and other assets | 16,625 | (5,159) | (5,116) |
Accounts payable | 1,090 | 18,489 | 16,515 |
Accrued expenses and other liabilities | (4,226) | 4,088 | 13,297 |
Net cash provided by (used for) operating activities | 4,946 | 6,806 | (36,248) |
INVESTING ACTIVITIES: | |||
Capital expenditures, including intangibles | (38,498) | (31,609) | (27,031) |
Proceeds from sale of fixed assets | 1,869 | 158 | 268 |
Proceeds from settlement of net investment hedges | 0 | 3,820 | 0 |
Proceeds from disposal of business, net | 0 | 0 | 1,837 |
Proceeds from disposal of joint venture, net | 0 | 0 | 20,999 |
Proceeds from sale of Canton Facility, net | 0 | 0 | 35,167 |
Investment in venture capital fund, net | (350) | (950) | (3,199) |
Net cash (used for) provided by investing activities | (36,979) | (28,581) | 28,041 |
FINANCING ACTIVITIES: | |||
Revolving credit facility borrowings | 117,369 | 21,562 | 91,913 |
Revolving credit facility payments | (96,568) | (18,000) | (64,000) |
Proceeds from issuance of debt | 35,757 | 38,940 | 45,753 |
Repayments of debt | (35,102) | (42,248) | (48,107) |
Earn-out consideration cash payment | 0 | (6,276) | 0 |
Other financing costs | (2,251) | (484) | (18) |
Repurchase of Common Shares to satisfy employee tax withholding | (1,720) | (791) | (2,665) |
Net cash provided by (used for) financing activities | 17,485 | (7,297) | 22,876 |
Effect of exchange rate changes on cash and cash equivalents | 591 | (1,677) | (3,041) |
Net change in cash and cash equivalents | (13,957) | (30,749) | 11,628 |
Cash and cash equivalents at beginning of period | 54,798 | 85,547 | 73,919 |
Cash and cash equivalents at end of period | 40,841 | 54,798 | 85,547 |
Supplemental disclosure of cash flow information: | |||
Cash paid for interest | 13,007 | 7,293 | 6,055 |
Cash paid for income taxes, net | $ 10,302 | $ 6,178 | $ 11,267 |
CONSOLIDATED STATEMENTS OF SHAR
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands | Total | Number of Common Shares outstanding | Number of treasury shares | Additional paid-in capital | Retained earnings | Accumulated other comprehensive (loss) income | |
Common stock beginning balance (in shares) at Dec. 31, 2020 | 27,006 | ||||||
Treasury stock beginning balance (in shares) at Dec. 31, 2020 | 1,960 | ||||||
Beginning balance at Dec. 31, 2020 | $ 296,634 | $ (60,482) | $ 234,409 | $ 212,342 | $ (89,635) | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Net (loss) income | 3,406 | 3,406 | |||||
Unrealized gain on derivatives, net | 1,019 | [1] | 1,019 | ||||
Currency translation adjustments | (8,408) | (8,408) | |||||
Issuance of Common Shares ( in shares) | 265 | 265 | |||||
Repurchased Common Shares for treasury, net (in shares) | 80 | 80 | |||||
Repurchased Common Shares for treasury, net | 5,218 | $ 5,218 | |||||
Share-based compensation, net | (1,919) | (1,919) | |||||
Common stock ending balance (in shares) at Dec. 31, 2021 | 27,191 | ||||||
Treasury stock ending balance (in shares) at Dec. 31, 2021 | 1,775 | ||||||
Ending balance at Dec. 31, 2021 | 295,950 | $ (55,264) | 232,490 | 215,748 | (97,024) | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Net (loss) income | (14,056) | (14,056) | |||||
Unrealized gain on derivatives, net | 53 | [1] | 53 | ||||
Currency translation adjustments | (6,171) | (6,171) | |||||
Issuance of Common Shares ( in shares) | 193 | 193 | |||||
Repurchased Common Shares for treasury, net (in shares) | 43 | 43 | |||||
Repurchased Common Shares for treasury, net | 4,898 | $ 4,898 | |||||
Share-based compensation, net | $ 268 | 268 | |||||
Common stock ending balance (in shares) at Dec. 31, 2022 | 27,341 | 27,341 | |||||
Treasury stock ending balance (in shares) at Dec. 31, 2022 | 1,625 | 1,625 | |||||
Ending balance at Dec. 31, 2022 | $ 280,942 | $ (50,366) | 232,758 | 201,692 | (103,142) | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Net (loss) income | (5,183) | (5,183) | |||||
Unrealized gain on derivatives, net | 1,236 | [1] | 1,236 | ||||
Currency translation adjustments | 9,118 | 9,118 | |||||
Issuance of Common Shares ( in shares) | 297 | 297 | |||||
Repurchased Common Shares for treasury, net (in shares) | 89 | 89 | |||||
Repurchased Common Shares for treasury, net | 7,022 | $ 7,022 | |||||
Share-based compensation, net | $ (5,418) | (5,418) | |||||
Common stock ending balance (in shares) at Dec. 31, 2023 | 27,549 | 27,549 | |||||
Treasury stock ending balance (in shares) at Dec. 31, 2023 | 1,417 | 1,417 | |||||
Ending balance at Dec. 31, 2023 | $ 287,717 | $ (43,344) | $ 227,340 | $ 196,509 | $ (92,788) | ||
[1] Net of tax expense of $328, $14 and $271 for the years ended December 31, 2023, 2022 and 2021, respectively. |
Organization and Nature of Busi
Organization and Nature of Business | 12 Months Ended |
Dec. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Nature of Business | Organization and Nature of Business Stoneridge, Inc. and its subsidiaries are global designers and manufacturers of highly engineered electrical and electronic systems, components and modules for the automotive, commercial, off-highway and agricultural vehicle markets. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Basis of Presentation The accompanying consolidated financial statements include the accounts of Stoneridge, Inc. and its wholly-owned subsidiaries (collectively, the “Company”). Intercompany transactions and balances have been eliminated in consolidation. The Company analyzes its ownership interests in accordance with Accounting Standards Codification (“ASC”) “Consolidations (Topic 810)” to determine whether they are a variable interest entity and, if so, whether the Company is the primary beneficiary. Prior to the sale of our investment in Minda Stoneridge Instruments Ltd. (“MSIL”) on December 30, 2021, the Company accounted for its 49% ownership in MSIL under the equity method of accounting. Accounting Estimates The preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including certain self-insured risks and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Because actual results could differ from those estimates, the Company revises its estimates and assumptions as new information becomes available. Cash and Cash Equivalents The Company’s cash and cash equivalents include actively traded money market funds with short-term investments in marketable securities, primarily U.S. government securities. Cash and cash equivalents are stated at cost, which approximates fair value, due to the highly liquid nature and short-term duration of the underlying securities with original maturities of 90 days or less. Accounts Receivable and Concentration of Credit Risk Revenues are principally generated from the automotive, commercial, off-highway and agricultural vehicle markets. The Company’s largest customers are PACCAR and Traton, primarily related to the Electronics reportable segment and accounted for the following percentages of consolidated net sales: 2023 2022 2021 PACCAR 16 % 15 % 6 % Traton 15 % 11 % 9 % Accounts receivable are recorded at the invoice price, net of an estimate of allowance for doubtful accounts and other reserves. Allowance for Doubtful Accounts The Company evaluates the collectability of accounts receivable based on a combination of factors. In circumstances where the Company is aware of a specific customer’s inability to meet its financial obligations, a specific allowance for doubtful accounts is recorded against amounts due to reduce the net recognized receivable to the amount the Company reasonably believes will be collected. Additionally, the Company reviews historical trends for collectability in determining an estimate for its allowance for doubtful accounts. If economic circumstances change substantially, estimates of the recoverability of amounts due to the Company could be reduced by a material amount. The Company does not have collateral requirements with its customers. Inventories Inventories are valued at the lower of cost (using either the first-in, first-out (“FIFO”) or average cost methods) or net realizable value. The Company evaluates and adjusts as necessary its excess and obsolescence reserve on a quarterly basis. Excess inventories are quantities of items that exceed anticipated sales or usage for a reasonable period. The Company has guidelines for calculating provisions for excess inventories based on the number of months of inventories on hand compared to anticipated sales or usage. Management uses its judgment to forecast sales or usage and to determine what constitutes a reasonable period. Inventory cost includes material, labor and overhead. Inventories consist of the following: December 31 2023 2022 Raw materials $ 142,744 $ 121,983 Work-in-progress 11,907 7,812 Finished goods 33,107 22,785 Total inventories, net $ 187,758 $ 152,580 Inventory valued using the FIFO method was $176,033 and $139,996 at December 31, 2023 and 2022, respectively. Inventory valued using the average cost method was $11,725 and $12,584 at December 31, 2023 and 2022, respectively. Long Term Supply Commitment In 2022, the Company entered into a long term supply agreement with a supplier for the purchase of certain electronic semiconductor components through December 31, 2026. Pursuant to the agreement, the Company paid capacity deposits of $1,000 in 2022 and 2023, respectively. The capacity deposits are recognized in prepaid and other current assets on our consolidated balance sheet. This long term supply agreement requires the Company to purchase minimum annual volumes while requiring the supplier to sell these components at a fixed price. The Company purchased $6,028 and $1,174 of these components during the years ended December 31, 2023 and 2022, respectively. The Company is required to purchase $7,828, $10,764 and $10,764 of components in each of the years 2024 through 2026, respectively. Pre-production Costs Related to Long-term Supply Arrangements Engineering, research and development and other design and development costs for products sold on long-term supply arrangements are expensed as incurred unless the Company has a contractual guarantee for reimbursement from the customer which are capitalized as pre-production costs. Costs for molds, dies and other tools used to make products sold on long-term supply arrangements for which the Company either has title to the assets or has the noncancelable right to use the assets during the term of the supply arrangement are capitalized in property, plant and equipment and amortized to cost of sales over the shorter of the term of the arrangement or over the estimated useful lives of the assets, typically three Disposal of Particulate Matter Sensor Business On March 8, 2021, the Company entered into an Asset Purchase Agreement (the “APA”) by and among the Company, the Company’s wholly owned subsidiary, Stoneridge Electronics AS, as the Sellers, and Standard Motor Products, Inc. (“SMP”) and SMP Poland SP Z O.O., as the Buyers. Pursuant to the APA, the Company agreed to sell to the Buyers the Company’s assets located in Lexington, Ohio and Tallinn, Estonia related to the manufacturing of particulate matter sensor products and related service part operations (together, the “PM sensor business”). The Buyers did not acquire any of the Company’s locations or employees. The purchase price for the sale of the PM sensor assets was $4,000 (subject to a post-closing inventory adjustment which was a payment to SMP of $1,133) plus the assumption of certain liabilities. The purchase price was allocated among PM sensor product lines, Gen 1 and Gen 2 as defined under the APA. The purchase price allocated to Gen 1 fixed assets and inventory and Gen 2 fixed assets was $3,214 and $786, respectively. The sale of the Gen 2 assets occurred during November 2021, upon completion of the Company’s supply commitments to certain customers. The Company and SMP also entered into certain ancillary agreements, including a contract manufacturing agreement, a transitional services agreement, and a supply agreement, pursuant to which the Company provided and was compensated for certain manufacturing, transitional, administrative and support services to SMP on a short-term basis. On March 8, 2021 the Company’s Control Devices segment recognized net sales and cost of goods sold ("COGS") of $971 and $898, respectively, for the one-time sale of Gen 1 inventory and a gain on disposal of $740 for the sale of Gen 1 fixed assets less transaction costs of $60 within selling, general and administrative ("SG&A") during the three months ended March 31, 2021. Pursuant to the contract manufacturing agreement, the Company produced and sold PM sensor Gen 1 finished goods inventory to SMP recognizing net sales of $8,042 in the year ended December 31, 2021. In addition, the Company received $308 and $783 for services provided pursuant to the transition services agreement which were recognized as a reduction in SG&A for the years ended December 31, 2022 and 2021, respectively. PM sensor Gen 1 net sales, including sales of $8,042 to SMP pursuant to the contract manufacturing agreement and the sale of Gen 1 inventory components of $2,283 and operating income were $12,592 and $1,415, respectively, for the year ended December 31, 2021. The Company completed the PM sensor Gen 2 product supply commitments and ended production on September 23, 2021. In November 2021, the Company’s Control Devices segment recognized proceeds of $786 and a gain on disposal of $408 for the sale of the Gen 2 fixed assets within SG&A, for the year ended December 31, 2021. Sale of Canton Facility On May 7, 2021, the Company entered into a Real Estate Purchase and Sale Agreement (the “Agreement”) with Sun Life Assurance Company of Canada, a Canadian corporation (the “Buyer”), to sell the Canton Facility for $38,200 (subject to adjustment pursuant to the Agreement). On June 17, 2021, pursuant to the Agreement, as amended after May 7, 2021, the Company closed the sale of the Canton Facility to the Buyer for an adjusted purchase price of $37,900. The Company recognized in the Control Devices segment, net proceeds of $35,167 and a gain, net of direct selling costs, of $30,718 within SG&A. Sale of MSIL On November 2, 2021, the Company entered into a Share Purchase Agreement (the “SPA”) with Minda Corporation Limited (“Minda”), as the buyer, and MSIL. Pursuant to the SPA the Company agreed to sell to Minda the Company’s minority interest in MSIL for approximately $21,500 equivalent Indian Rupee which was payable in U.S. dollars at closing. On December 30, 2021, pursuant to the SPA, the Company closed the sale of MSIL to Minda for $21,587. The Company recognized net proceeds of $20,999 and a gain, net of transaction costs, of $1,794. Property, Plant and Equipment Property, plant and equipment are recorded at cost and consist of the following: December 31 2023 2022 Land and land improvements $ 3,133 $ 3,030 Buildings and improvements 32,097 29,703 Machinery and equipment 254,738 247,237 Office furniture and fixtures 9,708 9,100 Tooling 47,191 42,950 Information technology 36,853 32,584 Vehicles 789 783 Leasehold improvements 5,249 5,199 Construction in progress 27,589 20,676 Total property, plant, and equipment 417,347 391,262 Less: accumulated depreciation (307,221) (286,619) Property, plant and equipment, net $ 110,126 $ 104,643 Depreciation is provided using the straight-line method over the estimated useful lives of the assets. Depreciation expense for the years ended December 31, 2023, 2022 and 2021 was $26,697, $26,687 and $27,823, respectively. Depreciable lives within each property classification are as follows: Buildings and improvements 10-40 years Machinery and equipment 3-10 years Office furniture and fixtures 3-10 years Tooling 2-7 years Information technology 3-7 years Vehicles 3-7 years Leasehold improvements shorter of lease term or 3-10 years Maintenance and repair expenditures that are not considered improvements and do not extend the useful life of the property, plant and equipment are charged to expense as incurred. Expenditures for improvements and major renewals are capitalized. When assets are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the accounts, and any gain or loss on the disposition is recorded in the consolidated statements of operations as a component of SG&A expenses. Impairment of Long-Lived or Finite-Lived Assets The Company reviews the carrying value of its long-lived assets and finite-lived intangible assets for impairment when events or circumstances indicate that their carrying value may not be recoverable. Factors the Company considers important that could trigger testing of the related asset groups for an impairment include current period operating or cash flow losses combined with a history of operating or cash flow losses, a projection or forecast that demonstrates continuing losses, significant adverse changes in the business climate within a particular business or current expectations that a long-lived asset will be sold or otherwise disposed of significantly before the end of its estimated useful life. To test for impairment, the estimated undiscounted cash flows expected to be generated from the use and disposal of the asset or asset group is compared to its carrying value. An asset group is established by identifying the lowest level of cash flows generated by the group of assets that are largely independent of cash flows of other assets. If cash flows cannot be separately and independently identified for a single asset, we will determine whether an impairment has occurred for the group of assets for which we can identify projected cash flows. If these undiscounted cash flows are less than their respective carrying values, an impairment charge would be recognized to the extent that the carrying values exceed estimated fair values. The estimation of undiscounted cash flows and fair value requires us to make assumptions regarding future operating results over the life of the asset or the life of the primary asset in the asset group. The results of the impairment testing are dependent on these estimates which require judgment. The occurrence of certain events, including changes in economic and competitive conditions, could impact cash flows eventually realized and management’s ability to accurately assess whether an asset is impaired. Goodwill and Other Intangible Assets Goodwill The total purchase price associated with acquisitions is allocated to the acquisition date fair values of identifiable assets acquired and liabilities assumed with the excess purchase price assigned to goodwill. Goodwill was $35,295 and $34,225 at December 31, 2023 and 2022, respectively, all of which relates to the Electronics segment. Goodwill is not amortized, but instead is tested for impairment at least annually, or earlier when events and circumstances indicate that it is more likely than not that such assets have been impaired, by applying a fair value-based test. In conducting our annual impairment assessment testing, we first perform a qualitative assessment of whether it is more likely than not that a reporting unit’s fair value is less than its carrying amount. If not, no further goodwill impairment testing is performed. If it is more likely than not that a reporting unit’s fair value is less than its carrying amount, or if we elect not to perform a qualitative assessment of a reporting unit, we then compare the fair value of the reporting unit to the related net book value. If the net book value of a reporting unit exceeds its fair value, an impairment loss is measured and recognized. The Company utilizes an income statement approach to estimate the fair value of a reporting unit and a market valuation approach to further support this analysis. The income approach is based on projected debt-free cash flow which is discounted to the present value using discount factors that consider the timing and risk of cash flows. We believe that this approach is appropriate because it provides a fair value estimate based on the reporting unit’s expected long-term operating cash flow performance. This approach also mitigates the impact of cyclical trends that occur in the industry. Fair value is estimated using internally developed forecasts, as well as commercial and discount rate assumptions. The discount rate used is the value-weighted average of our estimated cost of equity and of debt (“cost of capital”) derived using both known and estimated customary market metrics. Our weighted average cost of capital is adjusted to reflect a risk factor, if necessary. Other significant assumptions include terminal value growth rates, terminal value margin rates, future capital expenditures and changes in future working capital requirements. While there are inherent uncertainties related to the assumptions used and to management’s application of these assumptions to this analysis, we believe that the income statement approach provides a reasonable estimate of the fair value of a reporting unit. The market valuation approach is used to further support our analysis. There was no impairment of goodwill for the years ended December 31, 2023, 2022 or 2021. Goodwill and changes in the carrying amount of goodwill for the Electronics segment for the years ended December 31, 2023 and 2022 were as follows: 2023 2022 Balance at January 1 $ 34,225 $ 36,387 Currency translation 1,070 (2,162) Balance at December 31 $ 35,295 $ 34,225 The Company’s cumulative goodwill impairment loss since inception was $300,083 at December 31, 2023 and 2022, which includes Stoneridge Brazil’s goodwill impairment in 2014 and goodwill impairment recorded by the Company’s Control Devices segment in 2008 and 2004. Other Intangible Assets Other intangible assets, net at December 31, 2023 and 2022 consisted of the following: As of December 31, 2023 Acquisition Accumulated Net Customer lists $ 46,393 $ (27,580) $ 18,813 Tradenames 17,423 (9,118) 8,305 Technology and patents 13,636 (11,098) 2,538 Capitalized software development 23,023 (5,365) 17,658 Total $ 100,475 $ (53,161) $ 47,314 As of December 31, 2022 Acquisition Accumulated Net Customer lists $ 44,394 $ (23,355) $ 21,039 Tradenames 16,430 (7,761) 8,669 Technology and patents 12,921 (10,100) 2,821 Capitalized software development 15,591 (2,612) 12,979 Total $ 89,336 $ (43,828) $ 45,508 Other intangible assets, net at December 31, 2023 for customer lists, tradenames, technology and patents, and capitalized software development include $15,161, $3,439, $396 and $15,509, respectively, related to the Electronics segment. Customer lists, tradenames and technology of $3,652, $4,866 and $2,082, respectively, related to the Stoneridge Brazil segment at December 31, 2023. Capitalized software development and patents of $2,149 and $60, respectively, related to the Control Devices segment at December 31, 2023. The Company designs and develops software that will be embedded into certain products and sold to customers. Software development costs are capitalized after the software product development reaches technological feasibility and until the software product becomes available for general release to customers. These intangible assets are amortized using the straight-line method over estimated useful lives generally ranging from three The Company recognized $6,942, $7,003 and $6,006 of amortization expense related to intangible assets in 2023, 2022 and 2021, respectively. Amortization expense is included as a component of COGS, SG&A and design and development ("D&D") on the consolidated statements of operations. Annual amortization expense for intangible assets is estimated to be approximately $8,700 for the year 2024 and approximately $7,000 for the years 2025 through 2028. The weighted-average remaining amortization period is approximately 7 years . There were no intangible impairment charges for the years ended December 31, 2023, 2022 or 2021. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consist of the following: As of December 31 2023 2022 Compensation related liabilities $ 23,941 $ 19,015 Product warranty and recall obligations 14,381 9,040 Other (A) 25,881 37,985 Total accrued expenses and other current liabilities $ 64,203 $ 66,040 _____________________________ (A) “Other” is comprised of miscellaneous accruals, none of which individually contributed a significant portion of the total. Income Taxes The Company accounts for income taxes using the liability method. Deferred income taxes reflect the tax consequences on future years of differences between the tax basis of assets and liabilities and their financial reporting amounts. Future tax benefits are recognized to the extent that realization of such benefits is more likely than not to occur. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the period that includes the enactment date. Deferred tax assets are recognized to the extent that these assets are more likely than not to be realized (See Note 6). In making such a determination, the Company considers all available positive and negative evidence, including future release of existing taxable temporary differences, projected future taxable income, tax planning strategies, and results of recent operations. Certain deferred tax assets are dependent on future taxable income to be realized. Release of some or all of a valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded. The Company’s policy is to provide for uncertain tax positions and the related interest and penalties based upon management’s assessment of whether a tax benefit is more likely than not to be sustained upon examination by tax authorities. To the extent the Company prevails in matters for which a liability for an unrecognized tax benefit is established or is required to pay amounts in excess of the liability, the Company’s effective tax rate in a given financial statement period may be affected. The Company adjusts this liability in the period in which an uncertain tax position is effectively settled, the statute of limitations expires for the relevant taxing authority to examine the tax position, or more information becomes available. The Company has made an accounting policy election to reflect global intangible low-taxed income (“GILTI”) taxes, if any, as a current period tax expense when incurred. Currency Translation The financial statements of foreign subsidiaries, where the local currency is the functional currency, are translated into U.S. dollars using exchange rates in effect at the period end for assets and liabilities and average exchange rates during each reporting period for the results of operations. Adjustments resulting from translation of financial statements are reflected as a component of accumulated other comprehensive loss in the Company’s consolidated balance sheets. Foreign currency transactions are remeasured into the functional currency using translation rates in effect at the time of the transaction with the resulting adjustments included on the consolidated statements of operations within other expense, net. These foreign currency transaction losses, including the impact of hedging activities, were $1,226, $5,534 and $2,037 for the years ended December 31, 2023, 2022 and 2021, respectively. Revenue Recognition and Sales Commitments The Company recognizes revenue when obligations under the terms of a contract with our customer are satisfied; generally this occurs with the transfer of control of our products and services, which is usually when the parts are shipped or delivered to the customer’s premises. The Company recognizes monitoring service revenues over time, as the services are provided to customers. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. The transaction price will include estimates of variable consideration to the extent it is probable that a significant reversal of revenue recognized will not occur. Incidental items that are not significant in the context of the contract are recognized as expense. The Company collects certain taxes and fees on behalf of government agencies and remits such collections on a periodic basis. The taxes are collected from customers but are not included in net sales. Estimated returns are based on historical authorized returns. The Company often enters into agreements with its customers at the beginning of a given vehicle’s expected production life. Once such agreements are entered into, it is the Company’s obligation to fulfill the customers’ purchasing requirements for the entire production life of the vehicle. These agreements are subject to potential renegotiation from time to time, which may affect product pricing. See Note 3 for additional disclosure. Shipping and Handling Costs Shipping and handling costs are included in COGS on the consolidated statements of operations. Product Warranty and Recall Reserves Amounts accrued for product warranty and recall claims are established based on the Company’s best estimate of the amounts necessary to settle existing and future claims on products sold as of the balance sheet dates. These accruals are based on several factors including past experience, production changes, industry developments and various other considerations. Our estimate is based on historical trends of units sold and claim payment amounts, combined with our current understanding of the status of existing claims, forecasts of the resolution of existing claims, expected future claims on products sold and commercial discussions with our customers. The key factors in our estimate are the warranty period and the customer source. The Company can provide no assurances that it will not experience material claims or that it will not incur significant costs to defend or settle such claims beyond the amounts accrued. The current portion of the product warranty and recall reserve is included as a component of accrued expenses and other current liabilities on the consolidated balance sheets. Product warranty and recall includes $7,228 and $4,437 of a long-term liability at December 31, 2023 and 2022, respectively, which is included as a component of other long-term liabilities on the consolidated balance sheets. During the second quarter of 2023, the Company received a request for arbitration of warranty claims related to past sales of PM sensor products, a product line we exited in 2019. The claim notification was submitted by one of our customers seeking recovery for warranty related claims. Based on our review of the technical merits and specific claims as well as prior discussions with the customer, we believe these claims lack merit and are significantly overstated. While no assurances can be made as to the ultimate outcome of this matter, or any other future claims, we do not currently believe a material loss is probable. The following provides a reconciliation of changes in the product warranty and recall reserve: Year ended December 31, 2023 2022 Product warranty and recall at beginning of period $ 13,477 $ 9,846 Accruals for warranties established during period 15,057 9,917 Aggregate changes in pre-existing liabilities due to claim developments 1,199 1,502 Settlements made during the period (8,639) (7,351) Foreign currency translation 516 (437) Product warranty and recall at end of period $ 21,610 $ 13,477 Design and Development Costs Expenses associated with the development of new products, and changes to existing products, other than capitalized software development costs, are charged to expense as incurred, and are included in the Company’s consolidated statements of operations as a separate component of costs and expenses. These product development costs amounted to $71,075, $65,296 and $66,165 for the years ended December 31, 2023, 2022 and 2021, respectively, or 7.3%, 7.3% and 8.6% of net sales for these respective periods. Research and Development Activities The Company enters into research and development contracts with certain customers, which generally provide for reimbursement of costs. The Company incurred and was reimbursed for contracted research and development costs of $18,809, $23,784 and $15,849 for the years ended December 31, 2023, 2022 and 2021, respectively. Share-Based Compensation At December 31, 2023, the Company had two share-based compensation plans: (1) 2016 Long-Term Incentive Plan for employees and (2) the 2018 Amended and Restated Directors’ Restricted Shares Plan, for non-employee directors. See Note 8 for additional details on share-based compensation plans. Total compensation expense recognized as a component of SG&A expense on the consolidated statements of operations for share-based compensation arrangements was $3,322, $5,942 and $5,960 for the years ended December 31, 2023, 2022 and 2021, respectively. There was no share-based compensation expense capitalized in inventory during 2023, 2022 or 2021. Share-based compensation expense is calculated using estimated volatility and forfeitures based on historical data, future expectations and the expected term of the share-based compensation awards. Financial Instruments and Derivative Financial Instruments Financial instruments, including derivative financial instruments, held by the Company include cash and cash equivalents, accounts receivable, accounts payable, long-term debt and foreign currency forward contracts. The carrying value of cash and cash equivalents, accounts receivable and accounts payable is considered to be representative of fair value because of the short maturity of these instruments. See Note 10 for fair value disclosures of the Company’s financial instruments. Common Shares Held in Treasury The Company accounts for Common Shares held in treasury under the cost method (applied on a FIFO basis) and includes such shares as a reduction of total shareholders’ equity. (Loss) Earnings Per Share Basic (loss) earnings per share was computed by dividing net (loss) income by the weighted-average number of Common Shares outstanding for each respective period. Diluted earnings per share was calculated by dividing net (loss) income by the weighted-average of all potentially dilutive Common Shares that were outstanding during the periods presented. However, for all periods in which the Company recognized a net loss, the Company did not recognize the effect of the potential dilutive securities as their inclusion would be anti-dilutive. Potential dilutive shares of 227,741 and 232,458 for the years ended December 31, 2023 and December 31, 2022, respectively, were excluded from diluted loss per share because the effect would have been anti-dilutive. Actual weighted-average Common Shares outstanding used in calculating basic and diluted net (loss) income per share were as follows: Year ended December 31, 2023 2022 2021 Basic weighted-average Common Shares outstanding 27,442,984 27,258,456 27,114,359 Effect of dilutive shares — — 301,175 Diluted weighted-average Common Shares outstanding 27,442,984 27,258,456 27,415,534 There were 418,834, 767,593 and 580,116 performance-based right to receive Common Shares outstanding at December 31, 2023, 2022 and 2021. These performance-based restricted and right to receive Common Shares are included in the computation of diluted earnings per share based on the number of Common Shares that would be issuable if the end of the year were the end of the contingency period. Deferred Financing Costs, net Deferred financing costs are amortized over the life of the related financial instrument using the straight-line method, which approximates the effective interest method. Deferred financing cost amortization and debt discount accretion, for the years ended December 31, 2023, 2022 and 2021 was $1,190, $1,051 and $643, respectively, and is included as a component of interest expense, net in the consolidated statements of operations. In 2022, the Company capitalized $484 of deferred financing costs as a result of entering into Amendment No. 3 to the Fourth Amended and Restated Credit Facility. In connection with Amendment No. 3, the Company wrote off a portion of the previously recorded deferred financing costs of $365 in interest expense, net during the year ended December 31, 2022. In 2023, the Company capitalized $332 of deferred financing costs as a resulting of entering into Amendment No. 4 to the Fourth Amended and Restated Credit Facility. Additionally 2023, the Company capitalized $1,915 of deferred financing costs and wrote off $309 of previously recorded deferred financing costs as a result of entering into the Fifth Amended and Restated Credit Agreement. See Note 5 to the consolidated financial statements for additional details regarding the Credit Facility and related deferred financing costs. The Company has elected to continue to present deferred financing costs within long-term assets in the Company’s consolidated balance sheets. Deferred financing costs, net, were $2,057 and $996, as of December 31, 2023 and 2022, respectively. Changes in Accumulated Other Comprehensive Income (Loss) by Component Changes in accumulated other comprehensive income (loss) for the years ended December 31, 2023 and 2022 were as follows: Foreign Unrealized Total Balance at January 1, 2023 $ (103,374) $ 232 $ |
Revenue
Revenue | 12 Months Ended |
Dec. 31, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | Revenue Revenue is recognized when obligations under the terms of a contract with our customer are satisfied; generally this occurs with the transfer of control of our products and services, which is usually when the parts are shipped or delivered to the customer’s premises. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. The transaction price will include estimates of variable consideration to the extent it is probable that a significant reversal of revenue recognized will not occur. Incidental items that are not significant in the context of the contract are recognized as expense. The expected costs associated with our base warranties are recognized as expense when the products are sold. Customer returns only occur if products do not meet the specifications of the contract and are not connected to any repurchase obligations of the Company. The Company does not have any financing components or significant payment terms as payment occurs shortly after the point of sale. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction that are collected by the Company from a customer are excluded from revenue. Amounts billed to customers related to shipping and handling costs are included in net sales in the consolidated statements of operations. Shipping and handling costs associated with outbound freight after control over a product is transferred to the customer are accounted for as a fulfillment cost and are included in cost of sales. Revenue by Reportable Segment Control Devices. Our Control Devices segment designs and manufactures products that monitor, measure or activate specific functions within a vehicle. This segment includes product lines such as actuators, sensors, switches and connectors. We sell these products principally to the automotive market in the North American and Asia Pacific regions. To a lesser extent, we also sell these products to the commercial vehicle and agricultural markets in the North American and Asia Pacific regions. Our customers included in these markets primarily consist of original equipment manufacturers (“OEM”) and companies supplying components directly to the OEMs (“Tier 1 supplier”). Electronics. Our Electronics segment designs and manufactures driver information systems, vision and safety systems, connectivity and compliance products and electronic control units. These products are sold principally to the commercial and off-highway vehicle markets primarily through our OEM and aftermarket channels in the European, North American and Asia Pacific regions. Stoneridge Brazil. Our Stoneridge Brazil segment primarily serves the South American region and specializes in the design, manufacture and sale of vehicle tracking devices and monitoring services, vehicle security alarms and convenience accessories, in-vehicle audio and infotainment devices, driver information systems and telematics solutions. Stoneridge Brazil sells its products through the aftermarket distribution channel, to factory authorized dealer installers, also referred to as original equipment services and directly to OEMs. In addition, monitoring services and tracking devices are sold directly to corporate customers and individual consumers. The following tables disaggregate our revenue by reportable segment and geographical location (1) for the periods ended December 31, 2023, 2022 and 2021: Control Devices Electronics Stoneridge Brazil Consolidated Year ended December 31, 2023 2022 2021 2023 2022 2021 2023 2022 2021 2023 2022 2021 Net Sales: North America $ 290,213 $ 291,808 $ 282,525 $ 205,328 $ 153,120 $ 104,419 $ — $ — $ — $ 495,541 $ 444,928 $ 386,944 South America — — — — — — 57,214 52,230 56,777 57,214 52,230 56,777 Europe — — 12,681 360,682 347,129 248,468 — — — 360,682 347,129 261,149 Asia Pacific 51,852 50,788 60,569 10,529 4,848 5,023 — — — 62,381 55,636 65,592 Total net sales $ 342,065 $ 342,596 $ 355,775 $ 576,539 $ 505,097 $ 357,910 $ 57,214 $ 52,230 $ 56,777 $ 975,818 $ 899,923 $ 770,462 (1) Company sales based on geographic location are where the sale originates not where the customer is located. Performance Obligations For OEM and Tier 1 supplier customers, the Company typically enters into contracts to provide serial production parts that consist of a set of documents including, but not limited to, an award letter, master purchase agreement and master terms and conditions. For each production product, the Company enters into separate purchase orders that contain the product specifications and an agreed-upon price. The performance obligation does not exist until a customer release is received for a specific number of parts. The majority of the parts sold to OEM and Tier 1 supplier customers are customized to the specific customer, with the exception of MirrorEye camera monitor systems (“CMS”) sold through our aftermarket channel that are common across all customers. The transaction price is equal to the contracted price per part and there is no expectation of material variable consideration in the transaction price. For most customer contracts, the Company does not have an enforceable right to payment at any time prior to when the parts are shipped or delivered to the customer; therefore, the Company recognizes revenue at the point in time it satisfies a performance obligation by transferring control of a part to the customer. Certain customer contracts contain an enforceable right to payment if the customer terminates the contract for convenience and therefore are recognized over time using the cost to complete input method. Our aftermarket products are focused on meeting the demand for safety and compliance parts and accessories as well as repair and replacement parts and are sold primarily to aftermarket distributors and direct to consumers in our South American, European and North American markets. Aftermarket products have one type of performance obligation which is the delivery of aftermarket parts and spare parts. For aftermarket customers, the Company typically has standard terms and conditions for all customers. In addition, aftermarket products have alternative use as they can be sold to multiple customers. Revenue for aftermarket part production contracts is recognized at a point in time when the control of the parts transfer to the customer which is based on the shipping terms. Aftermarket contracts may include variable consideration related to discounts, rebates and extended warranties which are included in the transaction price upon recognizing the product revenue. A small portion of the Company’s sales are comprised of monitoring services that include both monitoring devices and fees to individual, corporate, fleet and cargo customers in our Stoneridge Brazil segment. These monitoring service contracts are generally not capable of being distinct and are accounted for as a single performance obligation. We recognize revenue for our monitoring products and services contracts over the life of the contract. There is no variable consideration associated with these contracts. The Company has the right to consideration from a customer in the amount that corresponds directly with the value to the customer of the Company’s performance to date. Therefore, the Company recognizes revenue over time using the practical expedient ASC 606-10-55-18 in the amount the Company has a “right to invoice” rather than selecting an output or input method. Contract Balances The Company had no material contract assets, contract liabilities or capitalized contract acquisition costs as of December 31, 2023 or 2022. |
Investments
Investments | 12 Months Ended |
Dec. 31, 2023 | |
Equity Method Investments and Joint Ventures [Abstract] | |
Investments | Investments Minda Stoneridge Instruments Ltd. The Company had a 49% equity interest in MSIL, a company based in India that manufactured electronics, instrumentation equipment and sensors primarily for the motorcycle, commercial vehicle and automotive markets. As discussed in Note 2, the Company sold its equity interest in MSIL on December 30, 2021. The investment was accounted for under the equity method of accounting. Equity in earnings of MSIL included in the consolidated statements of operations was $1,776 for the year ended December 31, 2021. PST Eletrônica Ltda. The Company had a 74% controlling interest in Stoneridge Brazil from December 31, 2011 through May 15, 2017. On May 16, 2017, the Company acquired the remaining 26% noncontrolling interest in Stoneridge Brazil. As part of the acquisition agreement, the Company was required to pay additional earn-out consideration based on Stoneridge Brazil’s financial performance in 2021. The final earn-out consideration of $8,272 was paid in the second quarter of 2022. See Note 10 for the fair value and foreign currency adjustments of the earn-out consideration for the current and prior periods. Other Investments |
Debt
Debt | 12 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Debt | Debt December 31, December 31, Interest rates at Maturity Revolving Credit Facility Credit Facility $ 189,346 $ 167,802 8.16 % November 2026 Debt Sweden short-term credit line — — Suzhou short-term credit line 2,113 1,450 3.25 % August 2024 Total debt 2,113 1,450 Less: current portion (2,113) (1,450) Total long-term debt, net $ — $ — Revolving Credit Facility On June 5, 2019, the Company entered into the Fourth Amended and Restated Credit Agreement, as amended, (the “Fourth Amended and Restated Credit Agreement”). The Fourth Amended and Restated Credit Agreement provided for a $300,000 senior secured revolving credit facility. As a result of entering into the Fourth Amended and Restated Credit Agreement and related amendments, the Company capitalized $332 and $484 of deferred financing costs during the years ended December 31, 2023 and 2022, respectively. The Company wrote off a portion of the previously recorded deferred financing costs of $365 in interest expense, net during the year ended December 31, 2022. On November 2, 2023, the Company entered into the Fifth Amended and Restated Credit Agreement (the “Credit Facility”). The Credit Facility provides for a $275,000 senior secured revolving credit facility and it replaced and superseded the Fourth Amended and Restated Credit Agreement. The Credit Facility has an accordion feature which allows the Company to increase the availability by up to $150,000 upon the satisfaction of certain conditions, including the consent of lenders providing the increase in commitments and also includes a letter of credit subfacility, swing line subfacility and multicurrency subfacility. The Credit Facility has a termination date of November 2, 2026. Borrowings under the Credit Facility bear interest at either the Base Rate or the SOFR rate, at the Company’s option, plus the applicable margin as set forth in the Credit Facility. The Credit Facility contains certain financial covenants that require the Company to maintain less than a maximum leverage ratio and more than a minimum interest coverage ratio. As a result of entering into the Fifth Amended and Restated Credit Agreement, the Company capitalized $1,915 of deferred financing costs and wrote off $309 of previously recorded deferred financing costs during the year ended December 31, 2023. The Credit Facility contains customary affirmative covenants and representations. The Credit Facility also contains customary negative covenants, which, among other things, are subject to certain exceptions, including restrictions on (i) indebtedness, (ii) liens, (iii) liquidations, mergers, consolidations and acquisitions, (iv) disposition of assets or subsidiaries, (v) affiliate transactions, (vi) continuation of or change in business, (vii) restricted payments, (viii) restrictions in agreements on dividends, intercompany loans and granting liens on the collateral, (ix) loans and investments and (x) changes in organizational documents and fiscal year. The Credit Facility contains customary events of default, subject to customary thresholds and exceptions, including, among other things, (i) non-payment of principal and non-payment of interest and fees, (ii) a material inaccuracy of a representation or warranty at the time made, (iii) a failure to comply with any covenant, subject to customary grace periods in the case of certain affirmative covenants, (iv) cross default of other debt, final judgments and other adverse orders in excess of $30,000, (v) any loan document shall cease to be a legal, valid and binding agreement, (vi) certain uninsured losses or proceedings against assets with a value in excess of $30,000, (vii) ERISA events, (viii) a change of control, or (ix) bankruptcy or insolvency proceedings. Borrowings outstanding on credit facilities were $189,346 and $167,802 at December 31, 2023 and 2022, respectively. The Company was in compliance with all credit facility covenants at December 31, 2023 and 2022. The Company also had outstanding letters of credit of $1,586 and $1,626 at December 31, 2023 and 2022, respectively. Debt The Company’s wholly-owned subsidiary located in Stockholm, Sweden (the "Stockholm subsidiary"), has an overdraft credit line which allows overdrafts on the subsidiary’s bank account up to a daily maximum level of 20,000 Swedish krona, or $1,987 and $1,922 at December 31, 2023 and 2022, respectively. At December 31, 2023 and December 31, 2022 there were no borrowings outstanding on this overdraft credit line. During the year ended December 31, 2023, the subsidiary borrowed and repaid 358,484 Swedish krona, or $35,610. The Stockholm subsidiary has pledged certain of its assets as collateral in order to obtain a guarantee of certain of the Stockholm subsidiary’s obligations to third parties. The Company’s wholly-owned subsidiary located in Suzhou, China (the "Suzhou subsidiary"), has lines of credit (the “Suzhou credit line”) which allow up to a maximum borrowing level of 20,000 Chinese yuan, or $2,818 and $2,900 at December 31, 2023 and 2022, respectively. At December 31, 2023 and 2022 there was $2,113 and $1,450, respectively, in borrowings outstanding on the Suzhou credit line with weighted-average interest rates of 3.25% and 3.70%, respectively. The Suzhou credit line is included on the consolidated balance sheet within current portion of debt. In addition, the Suzhou subsidiary has a bank acceptance draft line of credit which facilitates the extension of trade payable payment terms by 180 days. The bank acceptance draft line of credit allows up to a maximum borrowing level of 60,000 Chinese yuan, or $8,453 and $8,699 at December 31, 2023 and 2022, respectively. There was $2,387 and $1,998 utilized on the Suzhou bank acceptance draft line of credit at December 31, 2023 and 2022, respectively. The Suzhou bank acceptance draft line of credit is included on the consolidated balance sheet within accounts payable. At December 31, 2023, the future maturities of the Credit Facility and debt were as follows: Year ended December 31, 2024 $ 2,113 2025 — 2026 189,346 2027 — 2028 — Total $ 191,459 |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The income tax expense included in the accompanying consolidated statement of operations represents federal, state and foreign income taxes. The components of (loss) income before income taxes and the provision (benefit) for income taxes consist of the following: Year ended December 31, 2023 2022 2021 (Loss) income before income taxes: Domestic $ (29,658) $ (11,944) $ 11,596 Foreign 27,736 1,248 840 Total (loss) income before income taxes $ (1,922) $ (10,696) $ 12,436 Provision (benefit) for income taxes: Current: Federal $ 219 $ 435 $ — State and local (101) 747 294 Foreign 7,181 7,288 9,248 Total current provision $ 7,299 $ 8,470 $ 9,542 Deferred: Federal $ (2,265) $ (3,282) $ 714 State and local 2 (25) (55) Foreign (1,775) (1,803) (1,171) Total deferred benefit (4,038) (5,110) (512) Total income tax provision $ 3,261 $ 3,360 $ 9,030 A summary of the differences between the statutory federal income tax rate of 21.0% and the consolidated provision for income taxes is shown below. Year ended December 31, 2023 2022 2021 Statutory U.S. federal income tax (benefit) provision $ (403) $ (2,246) $ 2,612 State income taxes, net of federal tax benefit (136) 495 942 Tax credits and incentives (4,886) (3,906) (2,865) Foreign tax rate differential 706 910 730 Impact of change in enacted tax law 5 300 227 Change in valuation allowance 1,817 5,248 5,070 U.S. tax on foreign earnings 4,815 1,376 (347) Tax impact of unconsolidated subsidiaries — 395 1,828 Unremitted earnings on foreign subsidiaries — (898) 835 Non-deductible expenses 1,338 657 740 Compensation and benefits 306 774 358 Other (301) 255 (1,100) Provision for income taxes $ 3,261 $ 3,360 $ 9,030 Significant components of the Company’s deferred tax assets and liabilities were as follows: As of December 31, 2023 2022 Deferred tax assets: Inventories $ 1,678 $ 1,479 Employee compensation and benefits 2,324 2,078 Accrued liabilities and reserves 6,466 5,862 Property, plant and equipment 3,290 2,794 Tax loss carryforwards 18,129 16,997 Tax credit carryforwards 22,191 20,802 Capitalized research and development 4,345 4,785 Lease liability 2,351 2,817 Other 1,040 1,213 Gross deferred tax assets 61,814 58,827 Less: Valuation allowance (21,082) (18,496) Deferred tax assets less valuation allowance 40,732 40,331 Deferred tax liabilities: Property, plant and equipment (1,271) (2,038) Intangible assets (8,942) (10,056) Right-of-use-assets (2,059) (2,595) Other (5,292) (4,991) Gross deferred tax liabilities (17,564) (19,680) Net deferred tax assets $ 23,168 $ 20,651 The balance sheet classification of our net deferred tax asset is shown below: Year ended December 31, 2023 2022 Long-term deferred tax assets $ 30,392 $ 29,149 Long-term deferred tax liabilities (7,224) (8,498) Net deferred tax assets $ 23,168 $ 20,651 The Company has recognized deferred taxes related to foreign withholding taxes and the expected foreign currency impact upon repatriation from foreign subsidiaries not considered indefinitely reinvested. At December 31, 2023, the aggregate undistributed earnings of our foreign subsidiaries amounted to $27,211. Based on the Company’s review of both positive and negative evidence regarding the realizability of deferred tax assets at December 31, 2023, a valuation allowance is recorded against certain deferred tax assets based upon the conclusion that it was more likely than not they would not be realized. Certain deferred tax assets are dependent on future taxable income to be realized. The Company has net operating loss carry forwards of $39,638 and $77,027 for state and foreign tax jurisdictions, respectively. The state net operating losses expire from 2024-2043 or have indefinite lives and the foreign net operating losses expire from 2024-2028 or have indefinite lives. The Company has general business and foreign tax credit carry forwards of $20,422, $1,054 and $714 for U.S. federal, state and foreign jurisdictions, respectively. The U.S. federal general business credits, if unused, begin to expire in 2027, and the state and foreign tax credits expire at various times. The following is a reconciliation of the Company’s total gross unrecognized tax benefits: 2023 2022 2021 Balance as of January 1 $ 2,545 $ 2,891 $ 3,449 Tax positions related to the current year: Additions — — — Tax positions related to the prior years: Reductions — — — Expirations of statutes of limitation — (346) (558) Balance as of December 31 $ 2,545 $ 2,545 $ 2,891 The Company has classified its uncertain tax positions as a reduction to non-current deferred income tax assets. If the Company’s tax positions are sustained by the taxing authorities in favor of the Company, the amount that would affect the Company’s effective tax rate is approximately $2,545 at December 31, 2023 and 2022. The Company classifies interest expense and, if applicable, penalties which could be assessed related to unrecognized tax benefits as a component of income tax expense. For the years ended December 31, 2023, 2022 and 2021, the Company recognized no expense related to interest and penalties. On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022 ("IRA"), which, among other things, implemented a 15% minimum tax on financial statement income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. The IRA did not have a material impact on the Company's consolidated financial statements. The Company conducts business globally and, as a result, files income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. In the normal course of business, the Company is subject to examination by taxing authorities throughout the world. The following table summarizes the open tax years for each jurisdiction: Jurisdiction Open Tax Years U.S. Federal 2017-2023 Argentina 2018-2023 Brazil 2015-2023 China 2019-2023 France 2020-2023 Germany 2019-2023 Italy 2018-2023 Mauritius 2017-2023 Mexico 2018-2023 Netherlands 2019-2023 Sweden 2018-2023 United Kingdom 2022-2023 |
Leases
Leases | 12 Months Ended |
Dec. 31, 2023 | |
Leases [Abstract] | |
Leases | Leases Lessee The Company has various cancelable and noncancelable leased assets within all segments, which include certain properties, vehicles and equipment of which are all classified as operating leases. Payments for these leases are generally fixed; however, several of our leases are composed of variable lease payments including index-based payments or inflation-based payments based on a Consumer Price Index (“CPI”) or other escalators. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. Under Leases (Topic 842), the Company determines an arrangement is a lease when we have the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. Other than the leases that we have already identified, we are not aware of any material leases that have not yet commenced. For leases that have a calculated lease term of 12 months or less and do not include an option to purchase the underlying asset which we are reasonably certain to exercise, the Company has made the policy election to not apply the recognition requirements in Leases (Topic 842). For these short-term leases, the Company recognizes the lease as a period expense on a straight-line basis over the lease term and variable lease payments in the period in which the obligation for those payments is incurred. For the leases identified, right of use (“ROU”) assets and lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, the Company used the calculated incremental borrowing rate based on the information available at the implementation date, and going forward at the commencement date, in determining the present value of lease payments. The Company will use the implicit rate when readily determinable. The ROU asset includes the carrying amount of the lease liability, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. The Company’s lease terms may include options to extend or terminate the lease and such options are included in the lease term when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Lease expenses are recognized within COGS, SG&A and D&D costs in the consolidated statements of operations. The Company has made the policy election to account for lease and non-lease components as a single lease component for all of its leases. The components of lease expense are as follows: Year ended December 31, 2023 2022 Operating lease cost $ 4,532 $ 4,736 Short-term lease cost 675 958 Variable lease cost 706 585 Total lease cost $ 5,913 $ 6,279 Balance sheet information related to leases is as follows: As of December 31, 2023 2022 Assets: Operating lease right-of-use assets $ 10,795 $ 13,762 Liabilities: Operating lease current liability, included in other current liabilities $ 3,871 $ 3,938 Operating lease long-term liability 7,684 10,594 Total leased liabilities $ 11,555 $ 14,532 Maturities of operating lease liabilities are as follows: As of December 31, 2023 2024 $ 4,220 2025 3,488 2026 2,134 2027 1,060 2028 1,065 Thereafter 992 Total future minimum lease payments $ 12,959 Less: imputed interest (1,404) Total lease liabilities $ 11,555 Weighted-average remaining lease term and discount rate for operating leases is as follows: As of December 31, 2023 2022 Weighted-average remaining lease term (in years) 4.00 4.64 Weighted-average discount rate 5.98 % 5.67 % Other information: Year ended December 31, 2023 2022 Operating cash flows: Cash paid related to operating lease obligations $ 4,545 $ 4,649 Non-cash activity: Right-of-use assets obtained in exchange for operating lease obligations $ 250 $ 594 Lessor The Company, as lessor, entered into a lease with a third-party lessee effective July 1, 2020, of its Canton, Massachusetts facility. In conjunction with the Canton restructuring plan outlined in Note 12, the Company ceased operations at this facility in March 2020. As discussed in Note 2, the Company sold the Canton facility and assigned the lease to the buyer on June 17, 2021. The Company recognized lease income on a straight-line basis over the lease term until the time of the sale. The Company recognized, in its Control Devices segment, operating and variable lease income from leases in our consolidated statements of operations of $602 and $199, respectively, for the year ended December 31, 2021. |
Leases | Leases Lessee The Company has various cancelable and noncancelable leased assets within all segments, which include certain properties, vehicles and equipment of which are all classified as operating leases. Payments for these leases are generally fixed; however, several of our leases are composed of variable lease payments including index-based payments or inflation-based payments based on a Consumer Price Index (“CPI”) or other escalators. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. Under Leases (Topic 842), the Company determines an arrangement is a lease when we have the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. Other than the leases that we have already identified, we are not aware of any material leases that have not yet commenced. For leases that have a calculated lease term of 12 months or less and do not include an option to purchase the underlying asset which we are reasonably certain to exercise, the Company has made the policy election to not apply the recognition requirements in Leases (Topic 842). For these short-term leases, the Company recognizes the lease as a period expense on a straight-line basis over the lease term and variable lease payments in the period in which the obligation for those payments is incurred. For the leases identified, right of use (“ROU”) assets and lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, the Company used the calculated incremental borrowing rate based on the information available at the implementation date, and going forward at the commencement date, in determining the present value of lease payments. The Company will use the implicit rate when readily determinable. The ROU asset includes the carrying amount of the lease liability, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. The Company’s lease terms may include options to extend or terminate the lease and such options are included in the lease term when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Lease expenses are recognized within COGS, SG&A and D&D costs in the consolidated statements of operations. The Company has made the policy election to account for lease and non-lease components as a single lease component for all of its leases. The components of lease expense are as follows: Year ended December 31, 2023 2022 Operating lease cost $ 4,532 $ 4,736 Short-term lease cost 675 958 Variable lease cost 706 585 Total lease cost $ 5,913 $ 6,279 Balance sheet information related to leases is as follows: As of December 31, 2023 2022 Assets: Operating lease right-of-use assets $ 10,795 $ 13,762 Liabilities: Operating lease current liability, included in other current liabilities $ 3,871 $ 3,938 Operating lease long-term liability 7,684 10,594 Total leased liabilities $ 11,555 $ 14,532 Maturities of operating lease liabilities are as follows: As of December 31, 2023 2024 $ 4,220 2025 3,488 2026 2,134 2027 1,060 2028 1,065 Thereafter 992 Total future minimum lease payments $ 12,959 Less: imputed interest (1,404) Total lease liabilities $ 11,555 Weighted-average remaining lease term and discount rate for operating leases is as follows: As of December 31, 2023 2022 Weighted-average remaining lease term (in years) 4.00 4.64 Weighted-average discount rate 5.98 % 5.67 % Other information: Year ended December 31, 2023 2022 Operating cash flows: Cash paid related to operating lease obligations $ 4,545 $ 4,649 Non-cash activity: Right-of-use assets obtained in exchange for operating lease obligations $ 250 $ 594 Lessor The Company, as lessor, entered into a lease with a third-party lessee effective July 1, 2020, of its Canton, Massachusetts facility. In conjunction with the Canton restructuring plan outlined in Note 12, the Company ceased operations at this facility in March 2020. As discussed in Note 2, the Company sold the Canton facility and assigned the lease to the buyer on June 17, 2021. The Company recognized lease income on a straight-line basis over the lease term until the time of the sale. The Company recognized, in its Control Devices segment, operating and variable lease income from leases in our consolidated statements of operations of $602 and $199, respectively, for the year ended December 31, 2021. |
Share-Based Compensation Plans
Share-Based Compensation Plans | 12 Months Ended |
Dec. 31, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Share-Based Compensation Plans | Share-Based Compensation Plans In May 2016, the Company’s shareholders approved the 2016 Long-Term Incentive Plan (the “2016 Plan”) and reserved 1,800,000 Common Shares (of which the maximum number of Common Shares which may be issued). In May 2020, the Company’s shareholders approved an amendment to the 2016 Plan to increase by 1,100,000 the number of Common Shares authorized for issuance. The amendment to the 2016 Plan brought the total Common Shares available for issuance to 2,900,000. Under the 2016 Plan, as of December 31, 2023, the Company has granted 3,351,074 share units, of which 1,378,385 were time-based with cliff vesting using the straight-line method and 1,972,689 were performance-based. As of December 31, 2023, 1,624,076 of the shares granted have been forfeited. There are 1,173,002 shares available to be granted under the 2016 Plan at December 31, 2023. In 2023, 2022 and 2021, pursuant to the 2016 Plan, the Company granted time-based share units and performance-based performance shares. The majority of the time-based share units cliff vest three years after the date of grant. The performance-based performance shares vest and are no longer subject to forfeiture upon the recipient remaining an employee of the Company for three years from the date of grant and, for a portion of the annual awards, upon the Company attaining certain targets of performance measured against a peer group’s three year performance in terms of total shareholder return and, for the remaining portion of the annual awards, upon achieving certain earnings per share targets and return on invested capital targets established by the Company during the performance period of the award. The allocation of performance shares granted between total shareholder return, earnings per share and return on invested capital were as follows for the years ended December 31: 2023 2022 2021 Total shareholder return 45 % 45 % 45 % Earnings per share 36 % 36 % 36 % Return on invested capital 18 % 18 % 18 % In 2023, the Company granted retention-based phantom shares to certain employees that vest in June 2025 provided the employee remains employed with the Company. The phantom shares will settle in cash based on the volume-weighted average closing price of the Company's stock for a 30 day period prior to the vesting date. As of December 31, 2023, the Company has recorded a liability of $795 for the phantom shares which was included on the consolidated balance sheet as a component of other long-term liabilities. In April 2005, the Company adopted the Directors’ Restricted Shares Plan (the “Director Share Plan”) and reserved 500,000 Common Shares for issuance under the Director Share Plan. In May 2013, shareholders approved an amendment to the Director Share Plan to increase the number of shares for issuance by 200,000 to 700,000. In May 2018, the Company’s shareholders approved the 2018 Amended and Restated Director’s Restricted Shares Plan (the "2018 Director Share Plan") to increase the number of shares for issuance by 150,000 to 850,000. In May 2022, the Company's shareholders approved Amendment No. 1 to the 2018 Director Share Plan to increase the number of shares for issuance by 100,000 to 950,000. Under the 2018 Director Share Plan, the Company has cumulatively issued 866,716 restricted Common Shares. As such, there are 83,284 restricted Common Shares available to be issued on December 31, 2023. Shares issued annually under the 2018 Director Share Plan are no longer subject to forfeiture one year after the date of grant. Share Units and Performance Shares The fair value of the non-vested time-based share unit awards was calculated using the market value of the Common Shares on the date of issuance. The weighted-average grant-date fair value of time-based share units granted during the years ended December 31, 2023, 2022 and 2021 was $18.48, $18.71, and $35.13, respectively. The fair value of the non-vested performance-based performance share awards with a performance condition requiring the Company to obtain certain earnings per share and return on invested capital targets were estimated using the market value of the shares on the date of grant. The fair value of non-vested performance-based performance share awards with a market condition requiring the Company to obtain a total shareholder return target relative to a group of peer companies was estimated using a Monte Carlo valuation model taking into consideration the probability of achievement using multiple simulations. The awards that use earnings per share and return on invested capital as the performance target are expensed beginning when it is probable that the Company will meet the underlying performance condition. A summary of the status of the Company’s non-vested share units and performance shares as of December 31, 2023 and the changes during the year then ended, are presented below: Time-based awards Performance-based awards Share units Weighted- Performance Weighted- Non-vested as of January 1, 2023 570,803 $ 22.29 767,592 $ 24.03 Granted 253,630 $ 18.48 261,202 $ 17.08 Vested (264,566) $ 20.88 (6,289) $ 29.27 Forfeited or cancelled (149,151) $ 23.65 (603,556) $ 22.45 Non-vested as of December 31, 2023 410,716 $ 20.35 418,949 $ 21.89 A summary of the status of the Company’s non-vested share units and performance shares as of December 31, 2022 and the changes during the year then ended, are presented below: Time-based awards Performance-based awards Share units Weighted- Performance Weighted- Non-vested as of January 1, 2022 450,331 $ 26.55 578,985 $ 28.42 Granted 335,044 $ 18.71 361,982 $ 20.64 Vested (168,222) $ 27.12 (2,317) $ 22.70 Forfeited or cancelled (46,350) $ 20.17 (171,058) $ 31.75 Non-vested as of December 31, 2022 570,803 $ 22.29 767,592 $ 24.03 As of December 31, 2023 total unrecognized compensation cost related to non-vested time-based share units granted was $2,066 . That cost is expected to be recognized over a weighted-average period of 1.15 years. For the years ended December 31, 2023, 2022 and 2021, the total fair value of awards vested was $5,623, $3,334 and $9,637, respectively. As of December 31, 2023, there was no unrecognized compensation cost related to non-vested performance shares granted that are probable to vest. As noted above, the Company has issued and outstanding performance-based share units that use different performance targets (total shareholder return, earnings per share and return on invested capital). The excess tax deficiency (benefit) realized from the vesting of share units and performance shares of the share-based payment arrangements was $230 , $543 and $(563) for the years ended December 31, 2023, 2022 and 2021, respectively. |
Employee Benefit Plans
Employee Benefit Plans | 12 Months Ended |
Dec. 31, 2023 | |
Retirement Benefits [Abstract] | |
Employee Benefit Plans | Employee Benefit Plans The Company has certain defined contribution profit sharing and 401(k) plans covering substantially all of its employees in the United States and Europe. The Company provides matching contributions to the Company’s 401(k) plan. Company contributions are generally discretionary. For the years ended December 31, 2023, 2022 and 2021, expenses related to these plans amounted to $5,536, $4,883 and $5,082, respectively. |
Financial Instruments and Fair
Financial Instruments and Fair Value Measurements | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Financial Instruments and Fair Value Measurements | Financial Instruments and Fair Value Measurements Financial Instruments A financial instrument is cash or a contract that imposes an obligation to deliver or conveys a right to receive cash or another financial instrument. The carrying values of cash and cash equivalents, accounts receivable and accounts payable are considered to be representative of fair value because of the short maturity of these instruments. The fair value of debt approximates the carrying value of debt, due to the variable interest rate on the Credit Facility and the maturity of the remaining outstanding debt. Derivative Instruments and Hedging Activities On December 31, 2023, the Company had open Mexican peso-denominated foreign currency forward contracts. The Company used foreign currency forward contracts solely for hedging and not for speculative purposes during 2023 and 2022. Management believes that its use of these instruments to reduce risk is in the Company’s best interest. The counterparties to these financial instruments are financial institutions with investment grade credit ratings. Foreign Currency Exchange Rate Risk The Company conducts business internationally and, therefore, is exposed to foreign currency exchange rate risk. The Company uses derivative financial instruments as cash flow hedges and used net investment hedges to manage its exposure to fluctuations in foreign currency exchange rates by reducing the effect of such fluctuations on foreign currency denominated intercompany transactions, inventory purchases and other foreign currency exposures. Net Investment Hedges During 2021, the Company entered into two cross-currency swaps, designated as net investment hedges, with notional values of $25,000 each that were scheduled to mature in August 2026 and August 2028. These swaps hedged a portion of the net investment in a certain euro-denominated subsidiary. As a result of favorable market conditions during 2022 the Company unwound the two net investment hedges and recognized a net gain of $3,716, which was recorded on the Company’s consolidated balance sheet in accumulated other comprehensive loss. The cash received from the settlement of these swaps of $3,820 was classified in investing activities in the consolidated statement of cash flows. The Company elected to assess hedge effectiveness of the net investment hedges under the spot method. Accordingly, periodic changes in the fair value of the derivative instruments attributable to factors other than spot exchange rate variability were excluded from the measurement of hedge ineffectiveness and reported directly in earnings each reporting period. The change in fair value of these derivative instruments was recorded in cumulative translation adjustment, which is a component of accumulated other comprehensive loss in the consolidated balance sheets. The Company had no outstanding net investment hedges as of December 31, 2023 or 2022. Cash Flow Hedges The Company entered into foreign currency forward contracts to hedge the Mexican peso currency in 2023 and 2022. These forward contracts were executed to hedge forecasted transactions and have been accounted for as cash flow hedges. As such, gains and losses on derivatives qualifying as cash flow hedges are recorded in accumulated other comprehensive loss, to the extent that hedges are effective, until the underlying transactions are recognized in earnings. Unrealized amounts in accumulated other comprehensive loss will fluctuate based on changes in the fair value of hedge derivative contracts at each reporting period. The cash flow hedges were highly effective. The effectiveness of the transactions has been and will be measured on an ongoing basis using regression analysis and forecasted future purchases of the currency. In certain instances, the foreign currency forward contracts may not qualify for hedge accounting or are not designated as hedges and, therefore, are marked-to-market with gains and losses recognized in the Company’s consolidated statements of operations as a component of other expense, net. During 2023 and 2022, all of the Company’s foreign currency forward contracts were designated as cash flow hedges. The Company’s foreign currency forward contracts offset a portion of the gains and losses on the underlying foreign currency denominated transactions as follows: Mexican peso-denominated Foreign Currency Forward Contracts – Cash Flow Hedges The Company holds Mexican peso-denominated foreign currency forward contracts which expire ratably on a monthly basis from January 2024 to December 2024. The notional amounts at December 31, 2023 and 2022 related to Mexican peso-denominated foreign currency forward contracts were $26,613 and $0, respectively. The Company evaluated the effectiveness of the Mexican peso-denominated foreign currency forward contracts held as of December 31, 2023 and the year then ended, and concluded that the hedges were highly effective. Interest Rate Risk Interest Rate Risk – Cash Flow Hedge On February 18, 2020, the Company entered into a floating-to-fixed interest rate swap agreement (the “Swap”) with a notional amount of $50,000 to hedge its exposure to interest payment fluctuations on a portion of its Fourth Amended and Restated Credit Agreement borrowings. The Swap matured on March 10, 2023. The Swap was designated as a cash flow hedge of the variable interest rate obligation under the Company's Fourth Amended and Restated Credit Agreement . Accordingly, the change in fair value of the Swap was recognized in accumulated other comprehensive loss. The Swap agreement required monthly settlements on the same days that the Fourth Amended and Restated Credit Agreement interest payments were due and had a maturity date of March 10, 2023, which was prior to the Fourth Amended and Restated Credit Agreement maturity date of June 4, 2024. Under the Swap terms, the Company paid a fixed interest rate and received a floating interest rate based on the one-month LIBOR, with a floor. The critical terms of the Swap were aligned with the terms of the Fourth Amended and Restated Credit Agreement , resulting in no hedge ineffectiveness. The difference between amounts to be received and paid under the Swap were recognized as a component of interest expense, net on the consolidated statements of operations. The swap settlements (reduced) increased interest expense, net by $(290), $(156) and $651 for the years ended December 31, 2023, 2022 and 2021, respectively. The notional amounts and fair values of derivative instruments in the consolidated balance sheets were as follows: Notional amounts (A) Prepaid expenses As of December 31, 2023 2022 2023 2022 Derivatives designated as hedging instruments: Cash flow hedges: Forward currency contracts $ 26,613 $ — $ 1,858 $ — Interest rate swap $ — $ 50,000 $ — $ 294 _____________________________ (A) Notional amounts represent the gross contract of the derivatives outstanding in U.S. dollars. Gross amounts recorded for the cash flow hedges in other comprehensive income (loss) and in net (loss) income for the years ended December 31 were as follows: Gain (loss) recorded in other Gain (loss) reclassified from other comprehensive income (loss) income into net (loss) income (A) 2023 2022 2021 2023 2022 2021 Derivatives designated as cash flow hedges: Forward currency contracts $ 2,304 $ 1,346 $ 923 $ 446 $ 2,076 $ 448 Interest rate swap $ (4) $ 953 $ 164 $ 290 $ 156 $ (651) Derivatives designated as net investment hedges: Cross-currency swaps $ — $ 2,446 $ 1,270 $ — $ — $ — _____________________________ (A) Gains reclassified from comprehensive income (loss) into net (loss) income recognized in COGS in the Company’s consolidated statements of operations for the years ended December 31, 2023, 2022 and 2021 were $337, $1,572 and $341, respectively. Gains reclassified from other comprehensive income (loss) into net (loss) income recognized in SG&A in the Company’s consolidated statements of operations were $109, $504 and $107 for the years ended December 31, 2023, 2022 and 2021, respectively. Gains (losses) reclassified from other comprehensive income (loss) into net (loss) income recognized in interest expense, net in the Company’s consolidated statements of operations were $290 , $156 and $(651) for the years ended December 31, 2023, 2022 and 2021, respectively. Cash flows from derivatives used to manage foreign exchange and interest rate risks are classified as operating activities within the consolidated statements of cash flows. The Company has measured the ineffectiveness of the forward currency contracts and any amounts recognized in the consolidated financial statements were immaterial for the years ended December 31, 2023, 2022 and 2021. Fair Value Measurements Certain assets and liabilities held by the Company are measured at fair value on a recurring basis and are categorized using the three levels of the fair value hierarchy based on the reliability of the inputs used. Fair values estimated using Level 1 inputs consist of quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Fair values estimated using Level 2 inputs, other than quoted prices, are observable for the asset or liability, either directly or indirectly and include among other things, quoted prices for similar assets or liabilities in markets that are active or inactive as well as inputs other than quoted prices that are observable. For forward currency and cross-currency contracts, inputs include forward foreign currency exchange rates. For the interest rate swap, inputs included LIBOR. Fair values estimated using Level 3 inputs consist of significant unobservable inputs. The following table presents our assets and liabilities that are measured at fair value on a recurring basis and are categorized using the three levels of the fair value hierarchy based on the reliability of inputs used. December 31, 2023 2022 Fair values estimated using Fair Level 1 Level 2 Level 3 Fair Financial assets carried at fair value: Forward currency contracts $ 1,858 $ — $ 1,858 $ — $ — Interest rate swap — — — — 294 Total financial assets carried at fair value $ 1,858 $ — $ 1,858 $ — $ 294 The following table sets forth a summary of the change in fair value of the Company’s Level 3 financial liabilities related to earn-out consideration that are measured at fair value on a recurring basis. 2022 Balance at January 1 $ 7,351 Change in fair value — Foreign currency adjustments 921 Earn-out consideration cash payment $ (8,272) Balance at December 31 $ — The Company was required to pay the Stoneridge Brazil earn-out consideration based on Stoneridge Brazil’s financial performance in 2021. The fair value of the Stoneridge Brazil earn-out consideration was based on 2021 earnings before interest, taxes, depreciation and amortization. The Stoneridge Brazil earn-out consideration obligation was recorded within accrued expenses and other current liabilities in the consolidated balance sheet as of December 31, 2021. The earn-out consideration obligation of $8,272 was paid in April 2022 and recorded in the consolidated statement of cash flows within operating and financing activities in the amounts of $1,996 and $6,276, respectively, for the year ended December 31, 2022. There were no transfers in or out of Level 3 from other levels in the fair value hierarchy for the year ended December 31, 2023. No non-recurring fair value adjustments were required for nonfinancial assets for the years ended December 31, 2023 and 2022. Impairment of Long-Lived Assets or Finite-Lived Assets The Company reviews the carrying value of its long-lived assets and finite-lived intangible assets for impairment when events or circumstances indicate that their carrying value may not be recoverable. Factors the Company considers important that could trigger testing of the related asset groups for an impairment include current period operating or cash flow losses combined with a history of operating or cash flow losses, a projection or forecast that demonstrates continuing losses, significant adverse changes in the business climate within a particular business or current expectations that a long-lived asset will be sold or otherwise disposed of significantly before the end of its estimated useful life. To test for impairment, the estimated undiscounted cash flows expected to be generated from the use and disposal of the asset or asset group is compared to its carrying value. An asset group is established by identifying the lowest level of cash flows generated by the group of assets that are largely independent of cash flows of other assets. If cash flows cannot be separately and independently identified for a single asset, we will determine whether an impairment has occurred for the group of assets for which we can identify projected cash flows. If these undiscounted cash flows are less than their respective carrying values, an impairment charge would be recognized to the extent that the carrying values exceed estimated fair values. The estimation of undiscounted cash flows and fair value requires us to make assumptions regarding future operating results over the life of the asset or the life of the primary asset in the asset group. The results of the impairment testing are dependent on these estimates which require judgment. The occurrence of certain events, including changes in economic and competitive conditions, could impact cash flows eventually realized and management’s ability to accurately assess whether an asset is impaired. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies From time to time, we are subject to various legal actions and claims incidental to our business, including those arising out of breach of contracts, product warranties, product liability, patent infringement, regulatory matters and employment-related matters. The Company establishes accruals for matters which it believes that losses are probable and can be reasonably estimated. Although it is not possible to predict with certainty the outcome of these matters, the Company is of the opinion that the ultimate resolution of these matters will not have a material adverse effect on its consolidated results of operations or financial position. As a result of environmental studies performed at the Company’s former facility located in Sarasota, Florida, the Company became aware of soil and groundwater contamination at the site. The Company engaged an environmental engineering consultant to assess the level of contamination and to develop a remediation and monitoring plan for the site. Soil remediation at the site was completed during the year ended December 31, 2010. A remedial action plan was approved by the Florida Department of Environmental Protection and groundwater remediation began in the fourth quarter of 2015. During the years ended December 31, 2023, 2022 and 2021, the Company recognized expense of $125, $0 and $407, respectively, related to ground water remediation. At December 31, 2023 and 2022, the Company had accruals of $143 and $246 respectively, related to future remediation costs. At December 31, 2023 and 2022, $136 and $132, respectively, were recorded as a component of accrued expenses and other current liabilities on the consolidated balance sheets while the remaining amounts as of December 31, 2023 and 2022 were recorded as a component of other long-term liabilities. Costs associated with the recorded liability will be incurred to complete the groundwater remediation and monitoring. The recorded liability is based on assumptions in the remedial action plan as well as estimates for future remediation activities. Although the Company sold the Sarasota facility and related property in December 2011, the liability to remediate the site contamination remains the responsibility of the Company. Due to the ongoing site remediation, the Company is currently required to maintain a $1,489 letter of credit for the benefit of the buyer. The Company’s Stoneridge Brazil subsidiary has civil, labor and other tax contingencies (excluding income tax) for which the likelihood of loss is deemed to be reasonably possible, but not probable, by the Company which is supported by legal advisors in Brazil. As a result, no provision has been recorded with respect to these contingencies, which amounted to R$41,681 ($8,609) and R$47,820 ($9,165) at December 31, 2023 and 2022, respectively. An unfavorable outcome on these contingencies could result in significant cost to the Company and adversely affect its results of operations and cash flows. On August 12, 2020, the Brazilian Administrative Counsel for Economic Defense (“CADE”) issued a ruling against Stoneridge Brazil for abuse of dominance and market foreclosure through its prior use of exclusivity provisions in agreements with its distributors. The CADE tribunal imposed a R$7,995 ($1,651) fine which is included in the reasonably possible contingencies noted above. The Company continues to challenge this ruling in Brazilian federal courts to reverse this decision by the CADE tribunal. |
Restructuring and Business Real
Restructuring and Business Realignment | 12 Months Ended |
Dec. 31, 2023 | |
Restructuring and Related Activities [Abstract] | |
Restructuring and Business Realignment | Restructuring and Business Realignment On May 19, 2020, the Company committed to the strategic exit of its Control Devices particulate matter sensor product line ("PM Sensor Exit"). The decision to exit the PM sensor product line was made after consideration of the decline in the market outlook for diesel passenger vehicles, the current and expected profitability of the product line and the Company’s strategic focus on aligning resources with the greatest opportunities. In conjunction with the strategic exit of the PM sensor product line, the Company entered into an asset purchase agreement related to the sale of the PM sensor product line during the first quarter of 2021. Refer to Note 2 of the consolidated financial statements for additional details regarding this sale. As a result of the PM Sensor Exit, the Company recognized expense of $2,360 for the year ended December 31, 2021, for non-cash fixed asset charges, including impairment and accelerated depreciation of PM sensor related fixed assets, employee severance and termination costs and other related costs including supplier settlements. For the year ended December 31, 2021 restructuring related costs of $1,510, $642 and $208 were recognized in COGS, SG&A and D&D, respectively. The expenses for the PM Sensor Exit that relate to the Control Devices reportable segment include the following: Utilization Accrual as of January 1, 2022 2022 Charge Cash Non-Cash Accrual as of December 31, 2022 Employee termination benefits $ 35 $ — $ (35) $ — $ — Other related costs — — — — — Total $ 35 $ — $ (35) $ — $ — Utilization Accrual as of January 1, 2021 2021 Charge Cash Non-Cash Accrual as of December 31, 2021 Fixed asset impairment and accelerated depreciation $ — $ 188 $ — $ (188) $ — Employee termination benefits — 139 (104) — 35 Other related costs — 2,033 (2,033) — — Total $ — $ 2,360 $ (2,137) $ (188) $ 35 On January 10, 2019, the Company committed to a restructuring plan that resulted in the closure of the Canton, Massachusetts facility (“Canton Facility”) on March 31, 2020 and the consolidation of manufacturing operations at that site into other Company locations (“Canton Restructuring”). The costs for the Canton Restructuring included employee severance and termination costs, contract terminations costs, professional fees and other related costs such as moving and set-up costs for equipment and costs to restore the engineering function previously located at the Canton facility. As a result of the Canton Restructuring actions, the Company recognized expense of $13 for the year ended December 31, 2021, for employee severance and termination costs and other restructuring related costs. For the year ended December 31, 2021 severance and other restructuring related costs of $13 were recognized in D&D in the consolidated statement of operations. Refer to Note 2 to the consolidated financial statements for additional details regarding the sale of the Canton Facility. The expenses for the Canton Restructuring that relate to the Control Devices reportable segment include the following: Utilization Accrual as of January 1, 2022 2022 Charge Cash Non-Cash Accrual as of December 31, 2022 Employee termination benefits $ 93 $ — $ (93) $ — $ — Other related costs — — — — — Total $ 93 $ — $ (93) $ — $ — Utilization Accrual as of January 1, 2021 2021 Charge Cash Non-Cash Accrual as of December 31, 2021 Employee termination benefits $ 165 $ — $ (72) $ — $ 93 Other related costs — 13 (13) — — Total $ 165 $ 13 $ (85) $ — $ 93 In the fourth quarter of 2018, the Company undertook restructuring actions for the Electronics segment affecting the European Aftermarket business and China operations. In the second quarter of 2020, the Company finalized plans to move its European Aftermarket sales activities in Dundee, Scotland to a new location which resulted in incurring contract termination costs as well as employee severance and termination costs. In addition, the Company announced a restructuring program to transfer the European production of its controls product line to China. As a result of these actions, the Company recognized expense of $290 for the year ended December 31, 2021 for employee severance and termination costs and other related costs. Electronics segment restructuring costs recognized in COGS, SG&A and D&D in the consolidated statement of operations for the year ended December 31, 2021 were $37, $210 and $43, respectively. The expenses for the restructuring activities that relate to the Electronics reportable segment include the following: Utilization Accrual as of January 1, 2021 2021 Charge Cash Non-Cash Accrual as of December 31, 2021 Employee termination benefits $ 227 $ 50 $ (277) $ — $ — Other related costs — 240 (240) — — Total $ 227 $ 290 $ (517) $ — $ — In addition to the specific restructuring activities, the Company regularly evaluates the performance of its businesses and cost structures, including personnel, and makes necessary changes thereto in order to optimize its results. The Company also evaluates the required skill sets of its personnel and periodically makes strategic changes. As a consequence of these actions, the Company incurs severance related costs which are referred to as business realignment charges. Business realignment charges by reportable segment were as follows: Year ended December 31, 2023 2022 2021 Control Devices (A) $ 511 $ — $ 192 Electronics (B) 2,862 — 3 Stoneridge Brazil (C) — 98 59 Unallocated Corporate (D) 1,137 190 1,138 Total business realignment charges $ 4,510 $ 288 $ 1,392 _____________________________ (A) Severance costs for the year ended December 31, 2023 related to COGS and SG&A were $369 and $142, respectively. Severance costs for the year ended December 31, 2021 related to SG&A were $192. (B) Severance costs for the year ended December 31, 2023 related to COGS, SG&A and D&D were $423, $2,057 and $382, respectively. Severance costs (benefit) for the year ended December 31, 2021 related to COGS, SG&A and D&D were $1, $(7) and $9 respectively. (C) Severance costs for the year ended December 31, 2022 related to SG&A were $98. Severance costs for the year ended December 31, 2021 related to COGS and SG&A were $7 and $52, respectively. (D) Employee separation related costs for the year ended December 31, 2023 related to SG&A and D&D were $1,122 and $15, respectively. Severance costs for the years ended December 31, 2022 and 2021 related to SG&A were $190 and $1,138, respectively. Business realignment charges classified by statement of operations line item were as follows: Year ended December 31, 2023 2022 2021 Cost of goods sold $ 792 $ — $ 8 Selling, general and administrative 3,321 288 1,375 Design and development 397 — 9 Total business realignment charges $ 4,510 $ 288 $ 1,392 |
Segment Reporting
Segment Reporting | 12 Months Ended |
Dec. 31, 2023 | |
Segment Reporting [Abstract] | |
Segment Reporting | Segment Reporting Operating segments are defined as components of an enterprise that are evaluated regularly by the Company’s chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is the chief executive officer. The Company has three reportable segments, Control Devices, Electronics and Stoneridge Brazil, which also represent its operating segments. The Control Devices reportable segment produces actuators, sensors, switches and connectors. The Electronics reportable segment produces driver information systems, vision and safety systems, connectivity and compliance products and electronic control units. The Stoneridge Brazil reportable segment designs and manufactures vehicle tracking devices and monitoring services, vehicle security alarms and convenience accessories, in-vehicle audio and infotainment devices, driver information systems and telematics solutions. The accounting policies of the Company’s reportable segments are the same as those described in Note 2. The Company’s management evaluates the performance of its reportable segments based primarily on revenues from external customers, capital expenditures and operating income. Inter-segment sales are eliminated upon consolidation. The financial information presented below is for our three reportable operating segments and includes adjustments for unallocated corporate costs and intercompany eliminations, where applicable. Such costs and eliminations do not meet the requirements for being classified as an operating segment. Corporate costs include various support functions, such as accounting/finance, executive administration, human resources, information technology and legal. A summary of financial information by reportable segment is as follows: December 31, 2023 2022 2021 Net Sales: Control Devices $ 342,065 $ 342,596 $ 355,775 Inter-segment sales 3,195 2,719 3,502 Control Devices net sales 345,260 345,315 359,276 Electronics 576,539 505,097 357,910 Inter-segment sales 31,621 28,709 26,192 Electronics net sales 608,160 533,806 384,103 Stoneridge Brazil 57,214 52,230 56,777 Inter-segment sales 13 32 — Stoneridge Brazil net sales 57,227 52,262 56,777 Eliminations (34,829) (31,460) (29,694) Total net sales $ 975,818 $ 899,923 $ 770,462 Operating Income (Loss): Control Devices $ 13,582 $ 23,917 $ 54,933 Electronics 27,309 5,128 (12,502) Stoneridge Brazil 4,454 3,150 995 Unallocated Corporate (A) (32,509) (29,260) (28,015) Total operating income $ 12,836 $ 2,935 $ 15,411 Depreciation and Amortization: Control Devices $ 12,414 $ 13,521 $ 15,351 Electronics 14,035 13,913 12,487 Stoneridge Brazil 4,801 3,939 3,856 Unallocated Corporate 2,388 2,318 2,134 Total depreciation and amortization (B) $ 33,638 $ 33,691 $ 33,828 Interest Expense (Income), net: Control Devices $ 149 $ 93 $ 132 Electronics 1,771 1,009 462 Stoneridge Brazil (1,693) (1,282) (1,353) Unallocated Corporate 12,773 7,277 5,948 Total interest expense, net $ 13,000 $ 7,097 $ 5,189 Capital Expenditures: Control Devices $ 9,230 $ 12,620 $ 9,154 Electronics 18,313 10,479 9,735 Stoneridge Brazil 3,054 3,480 2,918 Unallocated Corporate (C) 1,229 653 1,142 Total capital expenditures $ 31,826 $ 27,232 $ 22,949 December 31, 2023 2022 Total Assets: Control Devices $ 159,612 $ 174,535 Electronics 404,994 369,232 Stoneridge Brazil 66,318 60,861 Corporate (C) 419,469 419,469 Eliminations (370,493) (371,992) Total assets $ 679,900 $ 652,105 The following table presents net sales and long-term assets for the geographic areas in which the Company operates: December 31, 2023 2022 2021 Net Sales: North America $ 495,541 $ 444,928 $ 386,944 South America 57,214 52,230 56,777 Europe and Other 423,063 402,765 326,741 Total net sales $ 975,818 $ 899,923 $ 770,462 December 31, 2023 2022 Long-term Assets: North America $ 92,419 $ 92,149 South America 32,679 31,796 Europe and Other 125,412 118,609 Total long-term assets $ 250,510 $ 242,554 _____________________________ (A) Unallocated Corporate expenses include, among other items, accounting/finance, human resources, information technology and legal costs as well as share-based compensation. (B) These amounts represent depreciation and amortization on property, plant and equipment and certain intangible assets. (C) Assets located at Corporate consist primarily of cash, intercompany receivables, fixed and leased assets for the headquarter building, information technology assets, equity investments and investments in subsidiaries. |
SCHEDULE II - VALUATION AND QUA
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS | 12 Months Ended |
Dec. 31, 2023 | |
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] | |
Valuation and Qualifying Accounts | SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS The following schedule provides the activity for accounts receivable reserves and valuation allowance for deferred tax assets for the years ended December 31, 2023, 2022 and 2021 (in thousands): Balance at Charged to Write-offs Balance at Accounts receivable reserves: Year ended December 31, 2023 $ 962 $ 412 $ (316) $ 1,058 Year ended December 31, 2022 $ 1,443 $ 1,255 $ (1,736) $ 962 Year ended December 31, 2021 $ 817 $ 1,030 $ (404) $ 1,443 Balance at Net additions Exchange rate Balance at Valuation allowance for deferred tax assets: Year ended December 31, 2023 $ 18,496 $ 1,865 $ 721 $ 21,082 Year ended December 31, 2022 $ 14,516 $ 4,975 $ (995) $ 18,496 Year ended December 31, 2021 $ 10,237 $ 4,768 $ (489) $ 14,516 |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Pay vs Performance Disclosure | |||
Net (loss) income | $ (5,183) | $ (14,056) | $ 3,406 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Dec. 31, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying consolidated financial statements include the accounts of Stoneridge, Inc. and its wholly-owned subsidiaries (collectively, the “Company”). Intercompany transactions and balances have been eliminated in consolidation. The Company analyzes its ownership interests in accordance with Accounting Standards Codification (“ASC”) “Consolidations (Topic 810)” to determine whether they are a variable interest entity and, if so, whether the Company is the primary beneficiary. Prior to the sale of our investment in Minda Stoneridge Instruments Ltd. (“MSIL”) on December 30, 2021, the Company accounted for its 49% ownership in MSIL under the equity method of accounting. |
Accounting Estimates | Accounting Estimates The preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including certain self-insured risks and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Because actual results could differ from those estimates, the Company revises its estimates and assumptions as new information becomes available. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company’s cash and cash equivalents include actively traded money market funds with short-term investments in marketable securities, primarily U.S. government securities. Cash and cash equivalents are stated at cost, which approximates fair value, due to the highly liquid nature and short-term duration of the underlying securities with original maturities of 90 days or less. |
Accounts Receivable and Concentration Of Credit Risk | Accounts Receivable and Concentration of Credit Risk Revenues are principally generated from the automotive, Accounts receivable are recorded at the invoice price, net of an estimate of allowance for doubtful accounts and other reserves. |
Allowance for Doubtful Accounts | Allowance for Doubtful Accounts The Company evaluates the collectability of accounts receivable based on a combination of factors. In circumstances where the Company is aware of a specific customer’s inability to meet its financial obligations, a specific allowance for doubtful accounts is recorded against amounts due to reduce the net recognized receivable to the amount the Company reasonably believes will be collected. Additionally, the Company reviews historical trends for collectability in determining an estimate for its allowance for doubtful accounts. If economic circumstances change substantially, estimates of the recoverability of amounts due to the Company could be reduced by a material amount. The Company does not have collateral requirements with its customers. |
Inventories | Inventories |
Long Term Supply Commitment | Long Term Supply Commitment |
Pre-Production Costs Related to Long-Term Supply Arrangements | Pre-production Costs Related to Long-term Supply Arrangements Engineering, research and development and other design and development costs for products sold on long-term supply arrangements are expensed as incurred unless the Company has a contractual guarantee for reimbursement from the customer which are capitalized as pre-production costs. Costs for molds, dies and other tools used to make products sold on long-term supply arrangements for which the Company either has title to the assets or has the noncancelable right to use the assets during the term of the supply arrangement are capitalized in property, plant and equipment and amortized to cost of sales over the shorter of the term of the arrangement or over the estimated useful lives of the assets, typically three |
Disposal of Particulate Matter Sensor Business | Disposal of Particulate Matter Sensor Business On March 8, 2021, the Company entered into an Asset Purchase Agreement (the “APA”) by and among the Company, the Company’s wholly owned subsidiary, Stoneridge Electronics AS, as the Sellers, and Standard Motor Products, Inc. (“SMP”) and SMP Poland SP Z O.O., as the Buyers. Pursuant to the APA, the Company agreed to sell to the Buyers the Company’s assets located in Lexington, Ohio and Tallinn, Estonia related to the manufacturing of particulate matter sensor products and related service part operations (together, the “PM sensor business”). The Buyers did not acquire any of the Company’s locations or employees. The purchase price for the sale of the PM sensor assets was $4,000 (subject to a post-closing inventory adjustment which was a payment to SMP of $1,133) plus the assumption of certain liabilities. The purchase price was allocated among PM sensor product lines, Gen 1 and Gen 2 as defined under the APA. The purchase price allocated to Gen 1 fixed assets and inventory and Gen 2 fixed assets was $3,214 and $786, respectively. The sale of the Gen 2 assets occurred during November 2021, upon completion of the Company’s supply commitments to certain customers. The Company and SMP also entered into certain ancillary agreements, including a contract manufacturing agreement, a transitional services agreement, and a supply agreement, pursuant to which the Company provided and was compensated for certain manufacturing, transitional, administrative and support services to SMP on a short-term basis. On March 8, 2021 the Company’s Control Devices segment recognized net sales and cost of goods sold ("COGS") of $971 and $898, respectively, for the one-time sale of Gen 1 inventory and a gain on disposal of $740 for the sale of Gen 1 fixed assets less transaction costs of $60 within selling, general and administrative ("SG&A") during the three months ended March 31, 2021. Pursuant to the contract manufacturing agreement, the Company produced and sold PM sensor Gen 1 finished goods inventory to SMP recognizing net sales of $8,042 in the year ended December 31, 2021. In addition, the Company received $308 and $783 for services provided pursuant to the transition services agreement which were recognized as a reduction in SG&A for the years ended December 31, 2022 and 2021, respectively. PM sensor Gen 1 net sales, including sales of $8,042 to SMP pursuant to the contract manufacturing agreement and the sale of Gen 1 inventory components of $2,283 and operating income were $12,592 and $1,415, respectively, for the year ended December 31, 2021. The Company completed the PM sensor Gen 2 product supply commitments and ended production on September 23, 2021. In November 2021, the Company’s Control Devices segment recognized proceeds of $786 and a gain on disposal of $408 for the sale of the Gen 2 fixed assets within SG&A, for the year ended December 31, 2021. Sale of Canton Facility On May 7, 2021, the Company entered into a Real Estate Purchase and Sale Agreement (the “Agreement”) with Sun Life Assurance Company of Canada, a Canadian corporation (the “Buyer”), to sell the Canton Facility for $38,200 (subject to adjustment pursuant to the Agreement). On June 17, 2021, pursuant to the Agreement, as amended after May 7, 2021, the Company closed the sale of the Canton Facility to the Buyer for an adjusted purchase price of $37,900. The Company recognized in the Control Devices segment, net proceeds of $35,167 and a gain, net of direct selling costs, of $30,718 within SG&A. Sale of MSIL On November 2, 2021, the Company entered into a Share Purchase Agreement (the “SPA”) with Minda Corporation Limited (“Minda”), as the buyer, and MSIL. Pursuant to the SPA the Company agreed to sell to Minda the Company’s minority interest in MSIL for approximately $21,500 equivalent Indian Rupee which was payable in U.S. dollars at closing. |
Property, Plant and Equipment | Maintenance and repair expenditures that are not considered improvements and do not extend the useful life of the property, plant and equipment are charged to expense as incurred. Expenditures for improvements and major renewals are capitalized. When assets are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the accounts, and any gain or loss on the disposition is recorded in the consolidated statements of operations as a component of SG&A expenses. |
Impairment of Long-Lived or Finite-Lived Assets | Impairment of Long-Lived or Finite-Lived Assets The Company reviews the carrying value of its long-lived assets and finite-lived intangible assets for impairment when events or circumstances indicate that their carrying value may not be recoverable. Factors the Company considers important that could trigger testing of the related asset groups for an impairment include current period operating or cash flow losses combined with a history of operating or cash flow losses, a projection or forecast that demonstrates continuing losses, significant adverse changes in the business climate within a particular business or current expectations that a long-lived asset will be sold or otherwise disposed of significantly before the end of its estimated useful life. To test for impairment, the estimated undiscounted cash flows expected to be generated from the use and disposal of the asset or asset group is compared to its carrying value. An asset group is established by identifying the lowest level of cash flows generated by the group of assets that are largely independent of cash flows of other assets. If cash flows cannot be separately and independently identified for a single asset, we will determine whether an impairment has occurred for the group of assets for which we can identify projected cash flows. If these undiscounted cash flows are less than their respective carrying values, an impairment charge would be recognized to the extent that the carrying values exceed estimated fair values. The estimation of undiscounted cash flows and fair value requires us to make assumptions regarding future operating results over the life of the asset or the life of the primary asset in the asset group. The results of the impairment testing are dependent on these estimates which require judgment. The occurrence of certain events, including changes in economic and competitive conditions, could impact cash flows eventually realized and management’s ability to accurately assess whether an asset is impaired. |
Goodwill and Other Intangible Assets | Goodwill and Other Intangible Assets Goodwill The total purchase price associated with acquisitions is allocated to the acquisition date fair values of identifiable assets acquired and liabilities assumed with the excess purchase price assigned to goodwill. Goodwill was $35,295 and $34,225 at December 31, 2023 and 2022, respectively, all of which relates to the Electronics segment. Goodwill is not amortized, but instead is tested for impairment at least annually, or earlier when events and circumstances indicate that it is more likely than not that such assets have been impaired, by applying a fair value-based test. In conducting our annual impairment assessment testing, we first perform a qualitative assessment of whether it is more likely than not that a reporting unit’s fair value is less than its carrying amount. If not, no further goodwill impairment testing is performed. If it is more likely than not that a reporting unit’s fair value is less than its carrying amount, or if we elect not to perform a qualitative assessment of a reporting unit, we then compare the fair value of the reporting unit to the related net book value. If the net book value of a reporting unit exceeds its fair value, an impairment loss is measured and recognized. The Company utilizes an income statement approach to estimate the fair value of a reporting unit and a market valuation approach to further support this analysis. The income approach is based on projected debt-free cash flow which is discounted to the present value using discount factors that consider the timing and risk of cash flows. We believe that this approach is appropriate because it provides a fair value estimate based on the reporting unit’s expected long-term operating cash flow performance. This approach also mitigates the impact of cyclical trends that occur in the industry. Fair value is estimated using internally developed forecasts, as well as commercial and discount rate assumptions. The discount rate used is the value-weighted average of our estimated cost of equity and of debt (“cost of capital”) derived using both known and estimated customary market metrics. Our weighted average cost of capital is adjusted to reflect a risk factor, if necessary. Other significant assumptions include terminal value growth rates, terminal value margin rates, future capital expenditures and changes in future working capital requirements. While there are inherent uncertainties related to the assumptions used and to management’s application of these assumptions to this analysis, we believe that the income statement approach provides a reasonable estimate of the fair value of a reporting unit. The market valuation approach is used to further support our analysis. There was no impairment of goodwill for the years ended December 31, 2023, 2022 or 2021. The Company’s cumulative goodwill impairment loss since inception was $300,083 at December 31, 2023 and 2022, which includes Stoneridge Brazil’s goodwill impairment in 2014 and goodwill impairment recorded by the Company’s Control Devices segment in 2008 and 2004. Other intangible assets, net at December 31, 2023 for customer lists, tradenames, technology and patents, and capitalized software development include $15,161, $3,439, $396 and $15,509, respectively, related to the Electronics segment. Customer lists, tradenames and technology of $3,652, $4,866 and $2,082, respectively, related to the Stoneridge Brazil segment at December 31, 2023. Capitalized software development and patents of $2,149 and $60, respectively, related to the Control Devices segment at December 31, 2023. The Company designs and develops software that will be embedded into certain products and sold to customers. Software development costs are capitalized after the software product development reaches technological feasibility and until the software product becomes available for general release to customers. These intangible assets are amortized using the straight-line method over estimated useful lives generally ranging from three The Company recognized $6,942, $7,003 and $6,006 of amortization expense related to intangible assets in 2023, 2022 and 2021, respectively. Amortization expense is included as a component of COGS, SG&A and design and development ("D&D") on the consolidated statements of operations. Annual amortization expense for intangible assets is estimated to be approximately $8,700 for the year 2024 and approximately $7,000 for the years 2025 through 2028. The weighted-average remaining amortization period is approximately 7 years . There were no intangible impairment charges for the years ended December 31, 2023, 2022 or 2021. |
Income Taxes | Income Taxes The Company accounts for income taxes using the liability method. Deferred income taxes reflect the tax consequences on future years of differences between the tax basis of assets and liabilities and their financial reporting amounts. Future tax benefits are recognized to the extent that realization of such benefits is more likely than not to occur. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the period that includes the enactment date. Deferred tax assets are recognized to the extent that these assets are more likely than not to be realized (See Note 6). In making such a determination, the Company considers all available positive and negative evidence, including future release of existing taxable temporary differences, projected future taxable income, tax planning strategies, and results of recent operations. Certain deferred tax assets are dependent on future taxable income to be realized. Release of some or all of a valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded. The Company’s policy is to provide for uncertain tax positions and the related interest and penalties based upon management’s assessment of whether a tax benefit is more likely than not to be sustained upon examination by tax authorities. To the extent the Company prevails in matters for which a liability for an unrecognized tax benefit is established or is required to pay amounts in excess of the liability, the Company’s effective tax rate in a given financial statement period may be affected. The Company adjusts this liability in the period in which an uncertain tax position is effectively settled, the statute of limitations expires for the relevant taxing authority to examine the tax position, or more information becomes available. The Company has made an accounting policy election to reflect global intangible low-taxed income (“GILTI”) taxes, if any, as a current period tax expense when incurred. |
Currency Translation | Currency Translation The financial statements of foreign subsidiaries, where the local currency is the functional currency, are translated into U.S. dollars using exchange rates in effect at the period end for assets and liabilities and average exchange rates during each reporting period for the results of operations. Adjustments resulting from translation of financial statements are reflected as a component of accumulated other comprehensive loss in the Company’s consolidated balance sheets. Foreign currency transactions are remeasured into the functional currency using translation rates in effect at the time of the transaction with the resulting adjustments included on the consolidated statements of operations within other expense, net. These foreign currency transaction losses, including the impact of hedging activities, were $1,226, $5,534 and $2,037 for the years ended December 31, 2023, 2022 and 2021, respectively. |
Revenue Recognition and Sales Commitments | Revenue Recognition and Sales Commitments The Company recognizes revenue when obligations under the terms of a contract with our customer are satisfied; generally this occurs with the transfer of control of our products and services, which is usually when the parts are shipped or delivered to the customer’s premises. The Company recognizes monitoring service revenues over time, as the services are provided to customers. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. The transaction price will include estimates of variable consideration to the extent it is probable that a significant reversal of revenue recognized will not occur. Incidental items that are not significant in the context of the contract are recognized as expense. The Company collects certain taxes and fees on behalf of government agencies and remits such collections on a periodic basis. The taxes are collected from customers but are not included in net sales. Estimated returns are based on historical authorized returns. The Company often enters into agreements with its customers at the beginning of a given vehicle’s expected production life. Once such agreements are entered into, it is the Company’s obligation to fulfill the customers’ purchasing requirements for the entire production life of the vehicle. These agreements are subject to potential renegotiation from time to time, which may affect product pricing. See Note 3 for additional disclosure. |
Shipping and Handling Costs | Shipping and Handling Costs Shipping and handling costs are included in COGS on the consolidated statements of operations. |
Product Warranty and Recall Reserves | Product Warranty and Recall Reserves Amounts accrued for product warranty and recall claims are established based on the Company’s best estimate of the amounts necessary to settle existing and future claims on products sold as of the balance sheet dates. These accruals are based on several factors including past experience, production changes, industry developments and various other considerations. Our estimate is based on historical trends of units sold and claim payment amounts, combined with our current understanding of the status of existing claims, forecasts of the resolution of existing claims, expected future claims on products sold and commercial discussions with our customers. The key factors in our estimate are the warranty period and the customer source. The Company can provide no assurances that it will not experience material claims or that it will not incur significant costs to defend or settle such claims beyond the amounts accrued. The current portion of the product warranty and recall reserve is included as a component of accrued expenses and other current liabilities on the consolidated balance sheets. Product warranty and recall includes $7,228 and $4,437 of a long-term liability at December 31, 2023 and 2022, respectively, which is included as a component of other long-term liabilities on the consolidated balance sheets. During the second quarter of 2023, the Company received a request for arbitration of warranty claims related to past sales of PM sensor products, a product line we exited in 2019. The claim notification was submitted by one of our customers seeking recovery for warranty related claims. Based on our review of the technical merits and specific claims as well as prior discussions with the customer, we believe these claims lack merit and are significantly overstated. While no assurances can be made as to the ultimate outcome of this matter, or any other future claims, we do not currently believe a material loss is probable. |
Design and Development Costs | Design and Development Costs Expenses associated with the development of new products, and changes to existing products, other than capitalized software development costs, are charged to expense as incurred, and are included in the Company’s consolidated statements of operations as a separate component of costs and expenses. These product development costs amounted to $71,075, $65,296 and $66,165 for the years ended December 31, 2023, 2022 and 2021, respectively, or 7.3%, 7.3% and 8.6% of net sales for these respective periods. |
Research and Development Activities | Research and Development Activities The Company enters into research and development contracts with certain customers, which generally provide for reimbursement of costs. The Company incurred and was reimbursed for contracted research and development costs of $18,809, $23,784 and $15,849 for the years ended December 31, 2023, 2022 and 2021, respectively. |
Share-Based Compensation | Share-Based Compensation At December 31, 2023, the Company had two share-based compensation plans: (1) 2016 Long-Term Incentive Plan for employees and (2) the 2018 Amended and Restated Directors’ Restricted Shares Plan, for non-employee directors. See Note 8 for additional details on share-based compensation plans. Total compensation expense recognized as a component of SG&A expense on the consolidated statements of operations for share-based compensation arrangements was $3,322, $5,942 and $5,960 for the years ended December 31, 2023, 2022 and 2021, respectively. There was no share-based compensation expense capitalized in inventory during 2023, 2022 or 2021. Share-based compensation expense is calculated using estimated volatility and forfeitures based on historical data, future expectations and the expected term of the share-based compensation awards. |
Financial Instruments and Derivative Financial Instruments | Financial Instruments and Derivative Financial Instruments Financial instruments, including derivative financial instruments, held by the Company include cash and cash equivalents, accounts receivable, accounts payable, long-term debt and foreign currency forward contracts. The carrying value of cash and cash equivalents, accounts receivable and accounts payable is considered to be representative of fair value because of the short maturity of these instruments. See Note 10 for fair value disclosures of the Company’s financial instruments. |
Common Shares Held in Treasury | Common Shares Held in Treasury The Company accounts for Common Shares held in treasury under the cost method (applied on a FIFO basis) and includes such shares as a reduction of total shareholders’ equity. |
(Loss) Earnings Per Share | (Loss) Earnings Per Share Basic (loss) earnings per share was computed by dividing net (loss) income by the weighted-average number of Common Shares outstanding for each respective period. Diluted earnings per share was calculated by dividing net (loss) income by the weighted-average of all potentially dilutive Common Shares that were outstanding during the periods presented. However, for all periods in which the Company recognized a net loss, the Company did not recognize the effect of the potential dilutive securities as their inclusion would be anti-dilutive. Potential dilutive shares of 227,741 and 232,458 for the years ended December 31, 2023 and December 31, 2022, respectively, were excluded from diluted loss per share because the effect would have been anti-dilutive. |
Deferred Finance Costs, net | Deferred Financing Costs, net Deferred financing costs are amortized over the life of the related financial instrument using the straight-line method, which approximates the effective interest method. Deferred financing cost amortization and debt discount accretion, for the years ended December 31, 2023, 2022 and 2021 was $1,190, $1,051 and $643, respectively, and is included as a component of interest expense, net in the consolidated statements of operations. In 2022, the Company capitalized $484 of deferred financing costs as a result of entering into Amendment No. 3 to the Fourth Amended and Restated Credit Facility. In connection with Amendment No. 3, the Company wrote off a portion of the previously recorded deferred financing costs of $365 in interest expense, net during the year ended December 31, 2022. In 2023, the Company capitalized $332 of deferred financing costs as a resulting of entering into Amendment No. 4 to the Fourth Amended and Restated Credit Facility. Additionally 2023, the Company capitalized $1,915 of deferred financing costs and wrote off $309 of previously recorded deferred financing costs as a result of entering into the Fifth Amended and Restated Credit Agreement. See Note 5 to the consolidated financial statements for additional details regarding the Credit Facility and related deferred financing costs. The Company has elected to continue to present deferred financing costs within long-term assets in the Company’s consolidated balance sheets. Deferred financing costs, net, were $2,057 and $996, as of December 31, 2023 and 2022, respectively. |
Reclassifications | Reclassifications Certain prior period amounts have been reclassified to conform to their 2023 presentation in the consolidated financial statements. |
Recently Adopted Accounting Standards and Recently Issued Accounting Standards Not Yet Adopted | Recently Adopted Accounting Standards In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-04, “Reference Rate Reform (Topic 848) – Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The guidance in ASU 2020-04 provides temporary optional expedient and exceptions to the guidance in U.S. GAAP on contract modifications and hedge accounting to ease the financial reporting burdens related to expected market transition from the London Interbank Offered Rate (“LIBOR”) and other interbank offered rates to alternative reference rates, such as the Secured Overnight Financing Rate (“SOFR”) (also known as the “reference rate reform”). The guidance allows companies to elect not to apply certain modification accounting requirements to contracts affected by the reference rate reform, if certain criteria are met. The guidance will also allow companies to elect various optional expedients which would allow them to continue to apply hedge accounting for hedging relationships affected by the reference rate reform, if certain criteria are met. The new standard was effective upon issuance and generally can be applied to applicable contract modifications through December 31, 2023. In February 2022, the Company amended its credit facility to incorporate hardwired mechanics to permit a future replacement of LIBOR as the interest reference rate without lender consent. The Company has applied the guidance to impacted transactions during the transition period. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements. Recently Issued Accounting Standards Not Yet Adopted as of December 31, 2023 In November 2023, the FASB issued ASU No. 2023-07, "Segment Reporting (Topic 280) – Improvements to Reportable Segment Disclosures", which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. The updated standard is effective for annual periods beginning in fiscal 2025 and interim periods beginning in the first quarter of fiscal 2026. Early adoption is permitted. We are currently evaluating the impact that the updated standard will have on our financial statement disclosures. In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740) – Improvements to Income Tax Disclosures," which requires companies to disclose, on an annual basis, specific categories in the effective tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. In addition, companies are required to disclose additional information about income taxes paid. The standard is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The standard is to be adopted on a prospective basis; however, retrospective application is permitted. We are currently evaluating the impact on our annual consolidated financial statement disclosures. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Schedule of Accounts Receivable and Concentration of Credit Risk | The Company’s largest customers are PACCAR and Traton, primarily related to the Electronics reportable segment and accounted for the following percentages of consolidated net sales: 2023 2022 2021 PACCAR 16 % 15 % 6 % Traton 15 % 11 % 9 % |
Schedule of Inventory, Current | Management uses its judgment to forecast sales or usage and to determine what constitutes a reasonable period. Inventory cost includes material, labor and overhead. Inventories consist of the following: December 31 2023 2022 Raw materials $ 142,744 $ 121,983 Work-in-progress 11,907 7,812 Finished goods 33,107 22,785 Total inventories, net $ 187,758 $ 152,580 |
Schedule of Property, Plant and Equipment | Property, plant and equipment are recorded at cost and consist of the following: December 31 2023 2022 Land and land improvements $ 3,133 $ 3,030 Buildings and improvements 32,097 29,703 Machinery and equipment 254,738 247,237 Office furniture and fixtures 9,708 9,100 Tooling 47,191 42,950 Information technology 36,853 32,584 Vehicles 789 783 Leasehold improvements 5,249 5,199 Construction in progress 27,589 20,676 Total property, plant, and equipment 417,347 391,262 Less: accumulated depreciation (307,221) (286,619) Property, plant and equipment, net $ 110,126 $ 104,643 |
Schedule of Property, Plant and Equipment Estimated Useful Lives | Depreciable lives within each property classification are as follows: Buildings and improvements 10-40 years Machinery and equipment 3-10 years Office furniture and fixtures 3-10 years Tooling 2-7 years Information technology 3-7 years Vehicles 3-7 years Leasehold improvements shorter of lease term or 3-10 years |
Schedule of Goodwill | Goodwill and changes in the carrying amount of goodwill for the Electronics segment for the years ended December 31, 2023 and 2022 were as follows: 2023 2022 Balance at January 1 $ 34,225 $ 36,387 Currency translation 1,070 (2,162) Balance at December 31 $ 35,295 $ 34,225 |
Schedule of Acquired Finite-Lived Intangible Assets by Major Class | Other intangible assets, net at December 31, 2023 and 2022 consisted of the following: As of December 31, 2023 Acquisition Accumulated Net Customer lists $ 46,393 $ (27,580) $ 18,813 Tradenames 17,423 (9,118) 8,305 Technology and patents 13,636 (11,098) 2,538 Capitalized software development 23,023 (5,365) 17,658 Total $ 100,475 $ (53,161) $ 47,314 As of December 31, 2022 Acquisition Accumulated Net Customer lists $ 44,394 $ (23,355) $ 21,039 Tradenames 16,430 (7,761) 8,669 Technology and patents 12,921 (10,100) 2,821 Capitalized software development 15,591 (2,612) 12,979 Total $ 89,336 $ (43,828) $ 45,508 |
Schedule of Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities consist of the following: As of December 31 2023 2022 Compensation related liabilities $ 23,941 $ 19,015 Product warranty and recall obligations 14,381 9,040 Other (A) 25,881 37,985 Total accrued expenses and other current liabilities $ 64,203 $ 66,040 _____________________________ (A) “Other” is comprised of miscellaneous accruals, none of which individually contributed a significant portion of the total. |
Schedule of Product Warranty and Recall Liability | The following provides a reconciliation of changes in the product warranty and recall reserve: Year ended December 31, 2023 2022 Product warranty and recall at beginning of period $ 13,477 $ 9,846 Accruals for warranties established during period 15,057 9,917 Aggregate changes in pre-existing liabilities due to claim developments 1,199 1,502 Settlements made during the period (8,639) (7,351) Foreign currency translation 516 (437) Product warranty and recall at end of period $ 21,610 $ 13,477 |
Schedule of Weighted-Average Number of Shares | Actual weighted-average Common Shares outstanding used in calculating basic and diluted net (loss) income per share were as follows: Year ended December 31, 2023 2022 2021 Basic weighted-average Common Shares outstanding 27,442,984 27,258,456 27,114,359 Effect of dilutive shares — — 301,175 Diluted weighted-average Common Shares outstanding 27,442,984 27,258,456 27,415,534 |
Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component | Changes in accumulated other comprehensive income (loss) for the years ended December 31, 2023 and 2022 were as follows: Foreign Unrealized Total Balance at January 1, 2023 $ (103,374) $ 232 $ (103,142) Other comprehensive income before reclassifications 9,118 1,817 10,935 Amounts reclassified from accumulated other comprehensive loss — (581) (581) Net other comprehensive income, net of tax 9,118 1,236 10,354 Balance at December 31, 2023 $ (94,256) $ 1,468 $ (92,788) Balance at January 1, 2022 $ (97,203) $ 179 $ (97,024) Other comprehensive (loss) income before reclassifications (6,171) 1,816 (4,355) Amounts reclassified from accumulated other comprehensive loss — (1,763) (1,763) Net other comprehensive (loss) income, net of tax (6,171) 53 (6,118) Balance at December 31, 2022 $ (103,374) $ 232 $ (103,142) |
Revenue (Tables)
Revenue (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Revenue by Segment and Geographical Location | The following tables disaggregate our revenue by reportable segment and geographical location (1) for the periods ended December 31, 2023, 2022 and 2021: Control Devices Electronics Stoneridge Brazil Consolidated Year ended December 31, 2023 2022 2021 2023 2022 2021 2023 2022 2021 2023 2022 2021 Net Sales: North America $ 290,213 $ 291,808 $ 282,525 $ 205,328 $ 153,120 $ 104,419 $ — $ — $ — $ 495,541 $ 444,928 $ 386,944 South America — — — — — — 57,214 52,230 56,777 57,214 52,230 56,777 Europe — — 12,681 360,682 347,129 248,468 — — — 360,682 347,129 261,149 Asia Pacific 51,852 50,788 60,569 10,529 4,848 5,023 — — — 62,381 55,636 65,592 Total net sales $ 342,065 $ 342,596 $ 355,775 $ 576,539 $ 505,097 $ 357,910 $ 57,214 $ 52,230 $ 56,777 $ 975,818 $ 899,923 $ 770,462 (1) Company sales based on geographic location are where the sale originates not where the customer is located. |
Debt (Tables)
Debt (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Schedule of Debt | December 31, December 31, Interest rates at Maturity Revolving Credit Facility Credit Facility $ 189,346 $ 167,802 8.16 % November 2026 Debt Sweden short-term credit line — — Suzhou short-term credit line 2,113 1,450 3.25 % August 2024 Total debt 2,113 1,450 Less: current portion (2,113) (1,450) Total long-term debt, net $ — $ — |
Schedule of Future Maturities of Long-Term Debt | At December 31, 2023, the future maturities of the Credit Facility and debt were as follows: Year ended December 31, 2024 $ 2,113 2025 — 2026 189,346 2027 — 2028 — Total $ 191,459 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Schedule of Components of Income Tax Expense (Benefit) | The components of (loss) income before income taxes and the provision (benefit) for income taxes consist of the following: Year ended December 31, 2023 2022 2021 (Loss) income before income taxes: Domestic $ (29,658) $ (11,944) $ 11,596 Foreign 27,736 1,248 840 Total (loss) income before income taxes $ (1,922) $ (10,696) $ 12,436 Provision (benefit) for income taxes: Current: Federal $ 219 $ 435 $ — State and local (101) 747 294 Foreign 7,181 7,288 9,248 Total current provision $ 7,299 $ 8,470 $ 9,542 Deferred: Federal $ (2,265) $ (3,282) $ 714 State and local 2 (25) (55) Foreign (1,775) (1,803) (1,171) Total deferred benefit (4,038) (5,110) (512) Total income tax provision $ 3,261 $ 3,360 $ 9,030 |
Schedule of Effective Income Tax Rate Reconciliation | A summary of the differences between the statutory federal income tax rate of 21.0% and the consolidated provision for income taxes is shown below. Year ended December 31, 2023 2022 2021 Statutory U.S. federal income tax (benefit) provision $ (403) $ (2,246) $ 2,612 State income taxes, net of federal tax benefit (136) 495 942 Tax credits and incentives (4,886) (3,906) (2,865) Foreign tax rate differential 706 910 730 Impact of change in enacted tax law 5 300 227 Change in valuation allowance 1,817 5,248 5,070 U.S. tax on foreign earnings 4,815 1,376 (347) Tax impact of unconsolidated subsidiaries — 395 1,828 Unremitted earnings on foreign subsidiaries — (898) 835 Non-deductible expenses 1,338 657 740 Compensation and benefits 306 774 358 Other (301) 255 (1,100) Provision for income taxes $ 3,261 $ 3,360 $ 9,030 |
Schedule of Deferred Tax Assets and Liabilities | Significant components of the Company’s deferred tax assets and liabilities were as follows: As of December 31, 2023 2022 Deferred tax assets: Inventories $ 1,678 $ 1,479 Employee compensation and benefits 2,324 2,078 Accrued liabilities and reserves 6,466 5,862 Property, plant and equipment 3,290 2,794 Tax loss carryforwards 18,129 16,997 Tax credit carryforwards 22,191 20,802 Capitalized research and development 4,345 4,785 Lease liability 2,351 2,817 Other 1,040 1,213 Gross deferred tax assets 61,814 58,827 Less: Valuation allowance (21,082) (18,496) Deferred tax assets less valuation allowance 40,732 40,331 Deferred tax liabilities: Property, plant and equipment (1,271) (2,038) Intangible assets (8,942) (10,056) Right-of-use-assets (2,059) (2,595) Other (5,292) (4,991) Gross deferred tax liabilities (17,564) (19,680) Net deferred tax assets $ 23,168 $ 20,651 |
Schedule of Classification of Net Deferred Tax Assets and Liability | The balance sheet classification of our net deferred tax asset is shown below: Year ended December 31, 2023 2022 Long-term deferred tax assets $ 30,392 $ 29,149 Long-term deferred tax liabilities (7,224) (8,498) Net deferred tax assets $ 23,168 $ 20,651 |
Schedule of Income Tax Contingencies | The following is a reconciliation of the Company’s total gross unrecognized tax benefits: 2023 2022 2021 Balance as of January 1 $ 2,545 $ 2,891 $ 3,449 Tax positions related to the current year: Additions — — — Tax positions related to the prior years: Reductions — — — Expirations of statutes of limitation — (346) (558) Balance as of December 31 $ 2,545 $ 2,545 $ 2,891 |
Schedule of Tax Years Open for Examination | The following table summarizes the open tax years for each jurisdiction: Jurisdiction Open Tax Years U.S. Federal 2017-2023 Argentina 2018-2023 Brazil 2015-2023 China 2019-2023 France 2020-2023 Germany 2019-2023 Italy 2018-2023 Mauritius 2017-2023 Mexico 2018-2023 Netherlands 2019-2023 Sweden 2018-2023 United Kingdom 2022-2023 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Leases [Abstract] | |
Schedule of Components of Lease Expense and Other Information | The components of lease expense are as follows: Year ended December 31, 2023 2022 Operating lease cost $ 4,532 $ 4,736 Short-term lease cost 675 958 Variable lease cost 706 585 Total lease cost $ 5,913 $ 6,279 Weighted-average remaining lease term and discount rate for operating leases is as follows: As of December 31, 2023 2022 Weighted-average remaining lease term (in years) 4.00 4.64 Weighted-average discount rate 5.98 % 5.67 % Other information: Year ended December 31, 2023 2022 Operating cash flows: Cash paid related to operating lease obligations $ 4,545 $ 4,649 Non-cash activity: Right-of-use assets obtained in exchange for operating lease obligations $ 250 $ 594 |
Schedule of Supplemental Balance Sheet Information | Balance sheet information related to leases is as follows: As of December 31, 2023 2022 Assets: Operating lease right-of-use assets $ 10,795 $ 13,762 Liabilities: Operating lease current liability, included in other current liabilities $ 3,871 $ 3,938 Operating lease long-term liability 7,684 10,594 Total leased liabilities $ 11,555 $ 14,532 |
Schedule of Maturities of Lease Liabilities | Maturities of operating lease liabilities are as follows: As of December 31, 2023 2024 $ 4,220 2025 3,488 2026 2,134 2027 1,060 2028 1,065 Thereafter 992 Total future minimum lease payments $ 12,959 Less: imputed interest (1,404) Total lease liabilities $ 11,555 |
Share-Based Compensation Plans
Share-Based Compensation Plans (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Schedule of the Allocation of Performance Shares Between Total Shareholder Return, Earnings per Share, and Return on Invested Capital | The allocation of performance shares granted between total shareholder return, earnings per share and return on invested capital were as follows for the years ended December 31: 2023 2022 2021 Total shareholder return 45 % 45 % 45 % Earnings per share 36 % 36 % 36 % Return on invested capital 18 % 18 % 18 % |
Schedule of Disclosure of Share-based Compensation Arrangements by Share-based Payment Award | A summary of the status of the Company’s non-vested share units and performance shares as of December 31, 2023 and the changes during the year then ended, are presented below: Time-based awards Performance-based awards Share units Weighted- Performance Weighted- Non-vested as of January 1, 2023 570,803 $ 22.29 767,592 $ 24.03 Granted 253,630 $ 18.48 261,202 $ 17.08 Vested (264,566) $ 20.88 (6,289) $ 29.27 Forfeited or cancelled (149,151) $ 23.65 (603,556) $ 22.45 Non-vested as of December 31, 2023 410,716 $ 20.35 418,949 $ 21.89 A summary of the status of the Company’s non-vested share units and performance shares as of December 31, 2022 and the changes during the year then ended, are presented below: Time-based awards Performance-based awards Share units Weighted- Performance Weighted- Non-vested as of January 1, 2022 450,331 $ 26.55 578,985 $ 28.42 Granted 335,044 $ 18.71 361,982 $ 20.64 Vested (168,222) $ 27.12 (2,317) $ 22.70 Forfeited or cancelled (46,350) $ 20.17 (171,058) $ 31.75 Non-vested as of December 31, 2022 570,803 $ 22.29 767,592 $ 24.03 |
Financial Instruments and Fai_2
Financial Instruments and Fair Value Measurements (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Notional Amounts and Fair Values of Derivative Instruments in the Consolidated Balance | The notional amounts and fair values of derivative instruments in the consolidated balance sheets were as follows: Notional amounts (A) Prepaid expenses As of December 31, 2023 2022 2023 2022 Derivatives designated as hedging instruments: Cash flow hedges: Forward currency contracts $ 26,613 $ — $ 1,858 $ — Interest rate swap $ — $ 50,000 $ — $ 294 _____________________________ (A) Notional amounts represent the gross contract of the derivatives outstanding in U.S. dollars. |
Amounts Recorded for the Cash Flow Hedges in Other Comprehensive Income (Loss) in Shareholders' Equity and in Net Income | Gross amounts recorded for the cash flow hedges in other comprehensive income (loss) and in net (loss) income for the years ended December 31 were as follows: Gain (loss) recorded in other Gain (loss) reclassified from other comprehensive income (loss) income into net (loss) income (A) 2023 2022 2021 2023 2022 2021 Derivatives designated as cash flow hedges: Forward currency contracts $ 2,304 $ 1,346 $ 923 $ 446 $ 2,076 $ 448 Interest rate swap $ (4) $ 953 $ 164 $ 290 $ 156 $ (651) Derivatives designated as net investment hedges: Cross-currency swaps $ — $ 2,446 $ 1,270 $ — $ — $ — _____________________________ (A) Gains reclassified from comprehensive income (loss) into net (loss) income recognized in COGS in the Company’s consolidated statements of operations for the years ended December 31, 2023, 2022 and 2021 were $337, $1,572 and $341, respectively. Gains reclassified from other comprehensive income (loss) into net (loss) income recognized in SG&A in the Company’s consolidated statements of operations were $109, $504 and $107 for the years ended December 31, 2023, 2022 and 2021, respectively. Gains (losses) reclassified from other comprehensive income (loss) into net (loss) income recognized in interest expense, net in the Company’s consolidated statements of operations were $290 |
Schedule of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis | The following table presents our assets and liabilities that are measured at fair value on a recurring basis and are categorized using the three levels of the fair value hierarchy based on the reliability of inputs used. December 31, 2023 2022 Fair values estimated using Fair Level 1 Level 2 Level 3 Fair Financial assets carried at fair value: Forward currency contracts $ 1,858 $ — $ 1,858 $ — $ — Interest rate swap — — — — 294 Total financial assets carried at fair value $ 1,858 $ — $ 1,858 $ — $ 294 |
Summary of the Change in Fair Value of the Level 3 Financial Liabilities Related to Contingent Consideration | The following table sets forth a summary of the change in fair value of the Company’s Level 3 financial liabilities related to earn-out consideration that are measured at fair value on a recurring basis. 2022 Balance at January 1 $ 7,351 Change in fair value — Foreign currency adjustments 921 Earn-out consideration cash payment $ (8,272) Balance at December 31 $ — |
Restructuring and Business Re_2
Restructuring and Business Realignment (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Restructuring Cost and Reserve [Line Items] | |
Schedule of Restructuring and Related Costs | Business realignment charges by reportable segment were as follows: Year ended December 31, 2023 2022 2021 Control Devices (A) $ 511 $ — $ 192 Electronics (B) 2,862 — 3 Stoneridge Brazil (C) — 98 59 Unallocated Corporate (D) 1,137 190 1,138 Total business realignment charges $ 4,510 $ 288 $ 1,392 _____________________________ (A) Severance costs for the year ended December 31, 2023 related to COGS and SG&A were $369 and $142, respectively. Severance costs for the year ended December 31, 2021 related to SG&A were $192. (B) Severance costs for the year ended December 31, 2023 related to COGS, SG&A and D&D were $423, $2,057 and $382, respectively. Severance costs (benefit) for the year ended December 31, 2021 related to COGS, SG&A and D&D were $1, $(7) and $9 respectively. (C) Severance costs for the year ended December 31, 2022 related to SG&A were $98. Severance costs for the year ended December 31, 2021 related to COGS and SG&A were $7 and $52, respectively. (D) Employee separation related costs for the year ended December 31, 2023 related to SG&A and D&D were $1,122 and $15, respectively. Severance costs for the years ended December 31, 2022 and 2021 related to SG&A were $190 and $1,138, respectively. |
Schedule of Business Realignment Charges Classified by Statement of Operations | Business realignment charges classified by statement of operations line item were as follows: Year ended December 31, 2023 2022 2021 Cost of goods sold $ 792 $ — $ 8 Selling, general and administrative 3,321 288 1,375 Design and development 397 — 9 Total business realignment charges $ 4,510 $ 288 $ 1,392 |
Control Devices | PM Sensor Exit | |
Restructuring Cost and Reserve [Line Items] | |
Schedule of Restructuring and Related Costs | The expenses for the PM Sensor Exit that relate to the Control Devices reportable segment include the following: Utilization Accrual as of January 1, 2022 2022 Charge Cash Non-Cash Accrual as of December 31, 2022 Employee termination benefits $ 35 $ — $ (35) $ — $ — Other related costs — — — — — Total $ 35 $ — $ (35) $ — $ — Utilization Accrual as of January 1, 2021 2021 Charge Cash Non-Cash Accrual as of December 31, 2021 Fixed asset impairment and accelerated depreciation $ — $ 188 $ — $ (188) $ — Employee termination benefits — 139 (104) — 35 Other related costs — 2,033 (2,033) — — Total $ — $ 2,360 $ (2,137) $ (188) $ 35 |
Control Devices | Canton Facility Restructuring Plan | |
Restructuring Cost and Reserve [Line Items] | |
Schedule of Restructuring and Related Costs | The expenses for the Canton Restructuring that relate to the Control Devices reportable segment include the following: Utilization Accrual as of January 1, 2022 2022 Charge Cash Non-Cash Accrual as of December 31, 2022 Employee termination benefits $ 93 $ — $ (93) $ — $ — Other related costs — — — — — Total $ 93 $ — $ (93) $ — $ — Utilization Accrual as of January 1, 2021 2021 Charge Cash Non-Cash Accrual as of December 31, 2021 Employee termination benefits $ 165 $ — $ (72) $ — $ 93 Other related costs — 13 (13) — — Total $ 165 $ 13 $ (85) $ — $ 93 |
Electronics | |
Restructuring Cost and Reserve [Line Items] | |
Schedule of Restructuring and Related Costs | The expenses for the restructuring activities that relate to the Electronics reportable segment include the following: Utilization Accrual as of January 1, 2021 2021 Charge Cash Non-Cash Accrual as of December 31, 2021 Employee termination benefits $ 227 $ 50 $ (277) $ — $ — Other related costs — 240 (240) — — Total $ 227 $ 290 $ (517) $ — $ — |
Segment Reporting (Tables)
Segment Reporting (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Segment Reporting [Abstract] | |
Schedule of Segment Reporting Information, by Segment | A summary of financial information by reportable segment is as follows: December 31, 2023 2022 2021 Net Sales: Control Devices $ 342,065 $ 342,596 $ 355,775 Inter-segment sales 3,195 2,719 3,502 Control Devices net sales 345,260 345,315 359,276 Electronics 576,539 505,097 357,910 Inter-segment sales 31,621 28,709 26,192 Electronics net sales 608,160 533,806 384,103 Stoneridge Brazil 57,214 52,230 56,777 Inter-segment sales 13 32 — Stoneridge Brazil net sales 57,227 52,262 56,777 Eliminations (34,829) (31,460) (29,694) Total net sales $ 975,818 $ 899,923 $ 770,462 Operating Income (Loss): Control Devices $ 13,582 $ 23,917 $ 54,933 Electronics 27,309 5,128 (12,502) Stoneridge Brazil 4,454 3,150 995 Unallocated Corporate (A) (32,509) (29,260) (28,015) Total operating income $ 12,836 $ 2,935 $ 15,411 Depreciation and Amortization: Control Devices $ 12,414 $ 13,521 $ 15,351 Electronics 14,035 13,913 12,487 Stoneridge Brazil 4,801 3,939 3,856 Unallocated Corporate 2,388 2,318 2,134 Total depreciation and amortization (B) $ 33,638 $ 33,691 $ 33,828 Interest Expense (Income), net: Control Devices $ 149 $ 93 $ 132 Electronics 1,771 1,009 462 Stoneridge Brazil (1,693) (1,282) (1,353) Unallocated Corporate 12,773 7,277 5,948 Total interest expense, net $ 13,000 $ 7,097 $ 5,189 Capital Expenditures: Control Devices $ 9,230 $ 12,620 $ 9,154 Electronics 18,313 10,479 9,735 Stoneridge Brazil 3,054 3,480 2,918 Unallocated Corporate (C) 1,229 653 1,142 Total capital expenditures $ 31,826 $ 27,232 $ 22,949 December 31, 2023 2022 Total Assets: Control Devices $ 159,612 $ 174,535 Electronics 404,994 369,232 Stoneridge Brazil 66,318 60,861 Corporate (C) 419,469 419,469 Eliminations (370,493) (371,992) Total assets $ 679,900 $ 652,105 |
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas | The following table presents net sales and long-term assets for the geographic areas in which the Company operates: December 31, 2023 2022 2021 Net Sales: North America $ 495,541 $ 444,928 $ 386,944 South America 57,214 52,230 56,777 Europe and Other 423,063 402,765 326,741 Total net sales $ 975,818 $ 899,923 $ 770,462 December 31, 2023 2022 Long-term Assets: North America $ 92,419 $ 92,149 South America 32,679 31,796 Europe and Other 125,412 118,609 Total long-term assets $ 250,510 $ 242,554 _____________________________ (A) Unallocated Corporate expenses include, among other items, accounting/finance, human resources, information technology and legal costs as well as share-based compensation. (B) These amounts represent depreciation and amortization on property, plant and equipment and certain intangible assets. (C) Assets located at Corporate consist primarily of cash, intercompany receivables, fixed and leased assets for the headquarter building, information technology assets, equity investments and investments in subsidiaries. |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies - Basis of Presentation (Details) | Dec. 30, 2021 | Dec. 29, 2021 |
Minda Stoneridge Instruments Ltd | ||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Equity method ownership percentage | 49% | 49% |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Schedule of Accounts Receivable and Concentration of Credit Risk (Details) - Revenue Benchmark - Customer Concentration Risk | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
PACCAR | |||
Segment Reporting, Revenue Reconciling Item [Line Items] | |||
Concentration risk percentage | 16% | 15% | 6% |
Traton | |||
Segment Reporting, Revenue Reconciling Item [Line Items] | |||
Concentration risk percentage | 15% | 11% | 9% |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies - Inventories (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Accounting Policies [Abstract] | ||
Raw materials | $ 142,744 | $ 121,983 |
Work-in-progress | 11,907 | 7,812 |
Finished goods | 33,107 | 22,785 |
Total inventories, net | 187,758 | 152,580 |
Inventory using the FIFO method | 176,033 | 139,996 |
Inventory using the average cost method | $ 11,725 | $ 12,584 |
Summary of Significant Accoun_7
Summary of Significant Accounting Policies - Long Term Supply Commitment (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Supply Commitment [Line Items] | ||
Capacity deposits | $ 1,000 | $ 1,000 |
Components to be paid in 2024 | 7,828 | |
Components to be paid in 2025 | 10,764 | |
Components to be paid in 2026 | 10,764 | |
Long Term Supply Agreement | ||
Supply Commitment [Line Items] | ||
Components purchased | $ 6,028 | $ 1,174 |
Summary of Significant Accoun_8
Summary of Significant Accounting Policies - Pre-production Costs Related to Long-term Supply Arrangements (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Business Acquisition [Line Items] | ||
Capitalized pre-production costs | $ 12,378 | $ 19,539 |
Minimum | Pre-production Costs | ||
Business Acquisition [Line Items] | ||
Estimated useful lives of the assets | 3 years | |
Maximum | Pre-production Costs | ||
Business Acquisition [Line Items] | ||
Estimated useful lives of the assets | 7 years |
Summary of Significant Accoun_9
Summary of Significant Accounting Policies - Disposal of Assets (Details) - USD ($) $ in Thousands | 12 Months Ended | |||||||
Dec. 30, 2021 | Jun. 17, 2021 | Mar. 08, 2021 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Nov. 02, 2021 | May 07, 2021 | |
Property, Plant and Equipment [Line Items] | ||||||||
Gain (loss) on disposal | $ 0 | $ 0 | $ 30,718 | |||||
Selling, general and administrative | 117,395 | 106,695 | 116,000 | |||||
Finished goods | $ 33,107 | 22,785 | ||||||
Particulate Matter Sensor Gen 1 Assets | ||||||||
Property, Plant and Equipment [Line Items] | ||||||||
Disposal group, net sales | 12,592 | |||||||
Finished goods | 2,283 | |||||||
Disposal group, operating income | 1,415 | |||||||
Particulate Matter Sensor Gen 1 Assets | Control Devices | ||||||||
Property, Plant and Equipment [Line Items] | ||||||||
Disposal group, net sales | $ 971 | |||||||
Predisposition intercompany purchases | 898 | |||||||
Gain (loss) on disposal | 740 | |||||||
Particulate Matter Sensor Gen 2 Assets | ||||||||
Property, Plant and Equipment [Line Items] | ||||||||
Gain (loss) on disposal | 408 | |||||||
Proceeds from sale of assets | 786 | |||||||
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Particulate Matter Sensor Assets | ||||||||
Property, Plant and Equipment [Line Items] | ||||||||
Purchase price for sale of assets | 4,000 | |||||||
Disposal group post-closing inventory adjustment payment | 1,133 | |||||||
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Particulate Matter Sensor Gen 1 Assets | ||||||||
Property, Plant and Equipment [Line Items] | ||||||||
Purchase price for sale of assets | 3,214 | |||||||
Disposal group, net sales | 8,042 | |||||||
Services provided pursuant to the agreement | $ 308 | $ 783 | ||||||
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Particulate Matter Sensor Gen 1 Assets | Control Devices | ||||||||
Property, Plant and Equipment [Line Items] | ||||||||
Selling, general and administrative | 60 | |||||||
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Particulate Matter Sensor Gen 2 Assets | ||||||||
Property, Plant and Equipment [Line Items] | ||||||||
Purchase price for sale of assets | $ 786 | |||||||
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Canton Facility | ||||||||
Property, Plant and Equipment [Line Items] | ||||||||
Purchase price for sale of assets | $ 38,200 | |||||||
Proceeds from sale of assets | $ 37,900 | |||||||
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Canton Facility | Control Devices | ||||||||
Property, Plant and Equipment [Line Items] | ||||||||
Gain (loss) on disposal | 30,718 | |||||||
Proceeds from sale of assets | $ 35,167 | |||||||
Disposal Group, Disposed of by Sale, Not Discontinued Operations | MSIL | ||||||||
Property, Plant and Equipment [Line Items] | ||||||||
Purchase price for sale of assets | $ 21,500 | |||||||
Gain (loss) on disposal | $ 1,794 | |||||||
Proceeds from sale of assets | 21,587 | |||||||
Proceeds from (payments related to) sale of business | $ 20,999 |
Summary of Significant Accou_10
Summary of Significant Accounting Policies - Property Plant and Equipment Net (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Property, Plant and Equipment [Line Items] | ||
Total property, plant, and equipment | $ 417,347 | $ 391,262 |
Less: accumulated depreciation | (307,221) | (286,619) |
Property, plant and equipment, net | 110,126 | 104,643 |
Land and land improvements | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant, and equipment | 3,133 | 3,030 |
Buildings and improvements | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant, and equipment | 32,097 | 29,703 |
Machinery and equipment | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant, and equipment | 254,738 | 247,237 |
Office furniture and fixtures | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant, and equipment | 9,708 | 9,100 |
Tooling | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant, and equipment | 47,191 | 42,950 |
Information technology | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant, and equipment | 36,853 | 32,584 |
Vehicles | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant, and equipment | 789 | 783 |
Leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant, and equipment | 5,249 | 5,199 |
Construction in progress | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant, and equipment | $ 27,589 | $ 20,676 |
Summary of Significant Accou_11
Summary of Significant Accounting Policies - Estimated Useful Lives of Property, Plant and Equipment (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Accounting Policies [Abstract] | |||
Depreciation expense | $ 26,697 | $ 26,687 | $ 27,823 |
Buildings and improvements | Minimum | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, useful life | 10 years | ||
Buildings and improvements | Maximum | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, useful life | 40 years | ||
Machinery and equipment | Minimum | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, useful life | 3 years | ||
Machinery and equipment | Maximum | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, useful life | 10 years | ||
Office furniture and fixtures | Minimum | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, useful life | 3 years | ||
Office furniture and fixtures | Maximum | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, useful life | 10 years | ||
Tooling | Minimum | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, useful life | 2 years | ||
Tooling | Maximum | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, useful life | 7 years | ||
Information technology | Minimum | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, useful life | 3 years | ||
Information technology | Maximum | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, useful life | 7 years | ||
Vehicles | Minimum | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, useful life | 3 years | ||
Vehicles | Maximum | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, useful life | 7 years | ||
Leasehold improvements | Minimum | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, useful life | 3 years | ||
Leasehold improvements | Maximum | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, useful life | 10 years |
Summary of Significant Accou_12
Summary of Significant Accounting Policies - Impairment of Assets and Goodwill (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Accounting Policies [Abstract] | |||
Goodwill | $ 35,295 | $ 34,225 | |
Impairment of goodwill | 0 | 0 | $ 0 |
Cumulative goodwill impairment | $ 300,083 | $ 300,083 |
Summary of Significant Accou_13
Summary of Significant Accounting Policies - Schedule of Goodwill (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Goodwill [Roll Forward] | ||
Balance at January 1 | $ 34,225 | |
Balance at December 31 | 35,295 | $ 34,225 |
Electronics | ||
Goodwill [Roll Forward] | ||
Balance at January 1 | 34,225 | 36,387 |
Currency translation | 1,070 | (2,162) |
Balance at December 31 | $ 35,295 | $ 34,225 |
Summary of Significant Accou_14
Summary of Significant Accounting Policies - Other Intangible Assets (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Acquisition cost | $ 100,475 | $ 89,336 | |
Accumulated amortization | (53,161) | (43,828) | |
Net | 47,314 | 45,508 | |
Amortization expense | 6,942 | 7,003 | $ 6,006 |
Amortization expense next year | 8,700 | ||
Amortization expense year two | 7,000 | ||
Amortization expense year three | 7,000 | ||
Amortization expense year four | 7,000 | ||
Amortization expense year five | $ 7,000 | ||
Weighted average remaining amortization period | 7 years | ||
Intangible impairment charge | $ 0 | 0 | $ 0 |
Customer lists | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Acquisition cost | 46,393 | 44,394 | |
Accumulated amortization | (27,580) | (23,355) | |
Net | 18,813 | 21,039 | |
Customer lists | Electronics | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Net | 15,161 | ||
Customer lists | Stoneridge Brazil | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Net | 3,652 | ||
Tradenames | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Acquisition cost | 17,423 | 16,430 | |
Accumulated amortization | (9,118) | (7,761) | |
Net | 8,305 | 8,669 | |
Tradenames | Electronics | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Net | 3,439 | ||
Tradenames | Stoneridge Brazil | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Net | 4,866 | ||
Technology and patents | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Acquisition cost | 13,636 | 12,921 | |
Accumulated amortization | (11,098) | (10,100) | |
Net | 2,538 | 2,821 | |
Technology and patents | Electronics | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Net | 396 | ||
Technology | Stoneridge Brazil | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Net | 2,082 | ||
Patents | Control Devices | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Net | 60 | ||
Capitalized software development | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Acquisition cost | 23,023 | 15,591 | |
Accumulated amortization | (5,365) | (2,612) | |
Net | 17,658 | $ 12,979 | |
Capitalized software development | Electronics | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Net | 15,509 | ||
Capitalized software development | Control Devices | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Net | $ 2,149 | ||
Capitalized software development | Minimum | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Estimated useful lives | 3 years | ||
Capitalized software development | Maximum | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Estimated useful lives | 7 years |
Summary of Significant Accou_15
Summary of Significant Accounting Policies - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Accounting Policies [Abstract] | ||
Compensation related liabilities | $ 23,941 | $ 19,015 |
Product warranty and recall obligations | 14,381 | 9,040 |
Other | 25,881 | 37,985 |
Total accrued expenses and other current liabilities | $ 64,203 | $ 66,040 |
Summary of Significant Accou_16
Summary of Significant Accounting Policies - Currency Translation and Product Warranty And Recall Reserves (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Accounting Policies [Abstract] | |||
Foreign currency transaction losses | $ 1,226 | $ 5,534 | $ 2,037 |
Product warranty and recall accrual | $ 7,228 | $ 4,437 |
Summary of Significant Accou_17
Summary of Significant Accounting Policies - Schedule of Product Warranty Liability (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward] | ||
Product warranty and recall at beginning of period | $ 13,477 | $ 9,846 |
Accruals for warranties established during period | 15,057 | 9,917 |
Aggregate changes in pre-existing liabilities due to claim developments | 1,199 | 1,502 |
Settlements made during the period | (8,639) | (7,351) |
Foreign currency translation | 516 | (437) |
Product warranty and recall at end of period | $ 21,610 | $ 13,477 |
Summary of Significant Accou_18
Summary of Significant Accounting Policies - Other Narrative (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Design and development | $ 71,075,000 | $ 65,296,000 | $ 66,165,000 |
Percentage of net sales | 7.30% | 7.30% | 8.60% |
Research and development expense reimbursed | $ 18,809,000 | $ 23,784,000 | $ 15,849,000 |
Share-based compensation expense | 3,322,000 | 5,942,000 | 5,960,000 |
Share-based compensation expense capitalized as inventory | $ 0 | $ 0 | 0 |
Potential dilutive shares (in shares) | 227,741 | 232,458 | |
Deferred financing cost amortization and debt discount accretion | $ 1,190,000 | $ 1,051,000 | $ 643,000 |
Deferred financing costs, net | 2,057,000 | 996,000 | |
Credit Facility | |||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Capitalized deferred financing costs | 484,000 | ||
Credit Facility | Credit Facility | |||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Write off of deferred financing costs | 309,000 | $ 365,000 | |
Fourth Amendment | |||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Capitalized deferred financing costs | 332,000 | ||
Fifth Amendment | |||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Capitalized deferred financing costs | $ 1,915,000 | ||
Performance Based Right to Receive Common Shares | |||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Common shares, non-vested | 418,834 | 767,593 | 580,116 |
Selling, general and administrative | |||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Share-based compensation expense | $ 3,322,000 | $ 5,942,000 | $ 5,960,000 |
Summary of Significant Accou_19
Summary of Significant Accounting Policies - Schedule of Weighted Average Number of Shares (Details) - shares | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Accounting Policies [Abstract] | |||
Basic weighted-average Common Shares outstanding (in shares) | 27,442,984 | 27,258,456 | 27,114,359 |
Effect of dilutive shares (in shares) | 0 | 0 | 301,175 |
Diluted weighted-average Common Shares outstanding (in shares) | 27,442,984 | 27,258,456 | 27,415,534 |
Summary of Significant Accou_20
Summary of Significant Accounting Policies - Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | |||
Beginning balance | $ 280,942 | $ 295,950 | $ 296,634 |
Other comprehensive (loss) income before reclassifications | 10,935 | (4,355) | |
Amounts reclassified from accumulated other comprehensive loss | (581) | (1,763) | |
Other comprehensive income (loss), net of tax | 10,354 | (6,118) | (7,389) |
Ending balance | 287,717 | 280,942 | 295,950 |
Accumulated other comprehensive (loss) income | |||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | |||
Beginning balance | (103,142) | (97,024) | (89,635) |
Ending balance | (92,788) | (103,142) | (97,024) |
Foreign currency translation | |||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | |||
Beginning balance | (103,374) | (97,203) | |
Other comprehensive (loss) income before reclassifications | 9,118 | (6,171) | |
Amounts reclassified from accumulated other comprehensive loss | 0 | 0 | |
Other comprehensive income (loss), net of tax | 9,118 | (6,171) | |
Ending balance | (94,256) | (103,374) | (97,203) |
Unrealized gain (loss) on derivatives | |||
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | |||
Beginning balance | 232 | 179 | |
Other comprehensive (loss) income before reclassifications | 1,817 | 1,816 | |
Amounts reclassified from accumulated other comprehensive loss | (581) | (1,763) | |
Other comprehensive income (loss), net of tax | 1,236 | 53 | |
Ending balance | $ 1,468 | $ 232 | $ 179 |
Revenue - Schedule of Revenue b
Revenue - Schedule of Revenue by Segment and Geographical Location (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disaggregation of Revenue [Line Items] | |||
Total net sales | $ 975,818 | $ 899,923 | $ 770,462 |
North America | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 495,541 | 444,928 | 386,944 |
South America | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 57,214 | 52,230 | 56,777 |
Europe | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 360,682 | 347,129 | 261,149 |
Asia Pacific | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 62,381 | 55,636 | 65,592 |
Control Devices | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 342,065 | 342,596 | 355,775 |
Control Devices | North America | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 290,213 | 291,808 | 282,525 |
Control Devices | South America | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 0 | 0 | 0 |
Control Devices | Europe | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 0 | 0 | 12,681 |
Control Devices | Asia Pacific | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 51,852 | 50,788 | 60,569 |
Electronics | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 576,539 | 505,097 | 357,910 |
Electronics | North America | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 205,328 | 153,120 | 104,419 |
Electronics | South America | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 0 | 0 | 0 |
Electronics | Europe | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 360,682 | 347,129 | 248,468 |
Electronics | Asia Pacific | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 10,529 | 4,848 | 5,023 |
Stoneridge Brazil | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 57,214 | 52,230 | 56,777 |
Stoneridge Brazil | North America | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 0 | 0 | 0 |
Stoneridge Brazil | South America | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 57,214 | 52,230 | 56,777 |
Stoneridge Brazil | Europe | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | 0 | 0 | 0 |
Stoneridge Brazil | Asia Pacific | |||
Disaggregation of Revenue [Line Items] | |||
Total net sales | $ 0 | $ 0 | $ 0 |
Revenue - Narrative (Details)
Revenue - Narrative (Details) - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
Revenue from Contract with Customer [Abstract] | ||
Contract assets | $ 0 | $ 0 |
Contract liabilities | 0 | 0 |
Capitalized contract acquisition costs | $ 0 | $ 0 |
Investments (Details)
Investments (Details) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended | 12 Months Ended | 61 Months Ended | 65 Months Ended | |||||
Dec. 31, 2018 | Jun. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2023 | May 15, 2017 | Dec. 30, 2021 | Dec. 29, 2021 | May 16, 2017 | |
Schedule of Equity Method Investments [Line Items] | ||||||||||
Income (loss) from equity method investments | $ (522) | $ (823) | $ 3,658 | |||||||
Investment | $ 46,980 | 44,416 | $ 46,980 | |||||||
Minda Stoneridge Instruments Ltd | ||||||||||
Schedule of Equity Method Investments [Line Items] | ||||||||||
Equity method investment, ownership percentage | 49% | 49% | ||||||||
Income (loss) from equity method investments | 1,776 | |||||||||
Stoneridge Brazil | ||||||||||
Schedule of Equity Method Investments [Line Items] | ||||||||||
Percentage ownership in consolidated subsidiary | 74% | |||||||||
Percentage of additional noncontrolling interest acquired | 26% | |||||||||
Fair value of earn-out liability | $ 8,272 | |||||||||
Autotech Ventures | ||||||||||
Schedule of Equity Method Investments [Line Items] | ||||||||||
Equity method investment, ownership percentage | 6.60% | 6.60% | ||||||||
Income (loss) from equity method investments | $ 522 | 823 | (1,882) | |||||||
Investment commitment | $ 10,000 | |||||||||
Contribution expected period | 10 years | |||||||||
Payments to acquire equity method investments | 350 | 950 | 3,450 | $ 8,400 | ||||||
Distributions received | $ 251 | |||||||||
Investment | $ 8,472 | $ 8,644 | $ 8,472 |
Debt - Schedule of Debt (Detail
Debt - Schedule of Debt (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Debt | ||
Total debt | $ 2,113,000 | $ 1,450,000 |
Less: current portion | (2,113,000) | (1,450,000) |
Total long-term debt, net | $ 0 | 0 |
Credit Facility | ||
Debt | ||
Outstanding credit lines interest rate | 8.16% | |
Sweden short-term credit line | ||
Revolving Credit Facility | ||
Revolving credit facility | $ 0 | 0 |
Debt | ||
Revolving credit facility | $ 0 | 0 |
Outstanding credit lines interest rate | ||
Suzhou short-term credit line | ||
Revolving Credit Facility | ||
Revolving credit facility | $ 2,113,000 | 1,450,000 |
Debt | ||
Revolving credit facility | $ 2,113,000 | $ 1,450,000 |
Outstanding credit lines interest rate | 3.25% |
Debt - Narrative (Details)
Debt - Narrative (Details) ¥ in Thousands, kr in Thousands | 12 Months Ended | ||||||||
Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Dec. 31, 2023 SEK (kr) | Dec. 31, 2023 CNY (¥) | Nov. 02, 2023 USD ($) | Dec. 31, 2022 SEK (kr) | Dec. 31, 2022 CNY (¥) | Jun. 05, 2019 USD ($) | |
Debt Instrument [Line Items] | |||||||||
Utilized amounts on line of credit | $ 117,369,000 | $ 21,562,000 | $ 91,913,000 | ||||||
Credit Facility | Credit Agreement | |||||||||
Debt Instrument [Line Items] | |||||||||
Line of credit facility, maximum borrowing capacity | $ 275,000,000 | $ 300,000,000 | |||||||
Write off of deferred financing costs | 365,000 | ||||||||
Increase in maximum borrowing capacity of credit facility | $ 150,000,000 | ||||||||
Debt instrument covenant default of other debt maximum amount | 30,000,000 | ||||||||
Debt instrument covenant uninsured asset losses maximum amount | 30,000,000 | ||||||||
Revolving credit facility | 189,346,000 | 167,802,000 | |||||||
Credit Facility | Fourth Amended And Restated Credit Agreement | |||||||||
Debt Instrument [Line Items] | |||||||||
Capitalized deferred financing costs | 332,000 | 484,000 | |||||||
Credit Facility | Fifth Amended And Restated Credit Agreement | |||||||||
Debt Instrument [Line Items] | |||||||||
Capitalized deferred financing costs | 1,915,000 | ||||||||
Write off of deferred financing costs | 309,000 | ||||||||
Letter of Credit | |||||||||
Debt Instrument [Line Items] | |||||||||
Outstanding letters of credit | 1,586,000 | 1,626,000 | |||||||
Line of credit | 1,489,000 | ||||||||
Sweden short-term credit line | |||||||||
Debt Instrument [Line Items] | |||||||||
Line of credit facility, maximum borrowing capacity | 1,987,000 | 1,922,000 | kr 20,000 | kr 20,000 | |||||
Revolving credit facility | 0 | 0 | |||||||
Line of credit | 35,610,000 | kr 358,484 | |||||||
Suzhou short-term credit line | |||||||||
Debt Instrument [Line Items] | |||||||||
Line of credit facility, maximum borrowing capacity | 2,818,000 | 2,900,000 | ¥ 20,000 | ¥ 20,000 | |||||
Revolving credit facility | $ 2,113,000 | $ 1,450,000 | |||||||
Outstanding credit lines weighted-average interest rate | 3.25% | 3.70% | 3.25% | 3.25% | 3.70% | 3.70% | |||
Payment term extension | 180 days | ||||||||
Credit facility, borrowing capacity | $ 8,453,000 | $ 8,699,000 | ¥ 60,000 | ¥ 60,000 | |||||
Utilized amounts on line of credit | $ 2,387,000 | $ 1,998,000 |
Debt - Schedule of Future Matur
Debt - Schedule of Future Maturities of Long-Term Debt (Details) $ in Thousands | Dec. 31, 2023 USD ($) |
Debt Disclosure [Abstract] | |
2024 | $ 2,113 |
2025 | 0 |
2026 | 189,346 |
2027 | 0 |
2028 | 0 |
Total | $ 191,459 |
Income Taxes - Schedule of Comp
Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
(Loss) income before income taxes: | |||
Domestic | $ (29,658) | $ (11,944) | $ 11,596 |
Foreign | 27,736 | 1,248 | 840 |
(Loss) income before income taxes | (1,922) | (10,696) | 12,436 |
Current: | |||
Federal | 219 | 435 | 0 |
State and local | (101) | 747 | 294 |
Foreign | 7,181 | 7,288 | 9,248 |
Total current provision | 7,299 | 8,470 | 9,542 |
Deferred: | |||
Federal | (2,265) | (3,282) | 714 |
State and local | 2 | (25) | (55) |
Foreign | (1,775) | (1,803) | (1,171) |
Total deferred benefit | (4,038) | (5,110) | (512) |
Total income tax provision | $ 3,261 | $ 3,360 | $ 9,030 |
Income Taxes - Schedule of Effe
Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Effective Income Tax Rate Reconciliation, Amount [Abstract] | |||
Statutory U.S. federal income tax (benefit) provision | $ (403) | $ (2,246) | $ 2,612 |
State income taxes, net of federal tax benefit | (136) | 495 | 942 |
Tax credits and incentives | (4,886) | (3,906) | (2,865) |
Foreign tax rate differential | 706 | 910 | 730 |
Impact of change in enacted tax law | 5 | 300 | 227 |
Change in valuation allowance | 1,817 | 5,248 | 5,070 |
U.S. tax on foreign earnings | 4,815 | 1,376 | (347) |
Tax impact of unconsolidated subsidiaries | 0 | 395 | 1,828 |
Unremitted earnings on foreign subsidiaries | 0 | (898) | 835 |
Non-deductible expenses | 1,338 | 657 | 740 |
Compensation and benefits | 306 | 774 | 358 |
Other | (301) | 255 | (1,100) |
Total income tax provision | $ 3,261 | $ 3,360 | $ 9,030 |
Income Taxes - Schedule of Defe
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Deferred tax assets: | ||
Inventories | $ 1,678 | $ 1,479 |
Employee compensation and benefits | 2,324 | 2,078 |
Accrued liabilities and reserves | 6,466 | 5,862 |
Property, plant and equipment | 3,290 | 2,794 |
Tax loss carryforwards | 18,129 | 16,997 |
Tax credit carryforwards | 22,191 | 20,802 |
Capitalized research and development | 4,345 | 4,785 |
Lease liability | 2,351 | 2,817 |
Other | 1,040 | 1,213 |
Gross deferred tax assets | 61,814 | 58,827 |
Less: Valuation allowance | (21,082) | (18,496) |
Deferred tax assets less valuation allowance | 40,732 | 40,331 |
Deferred tax liabilities: | ||
Property, plant and equipment | (1,271) | (2,038) |
Intangible assets | (8,942) | (10,056) |
Right-of-use-assets | (2,059) | (2,595) |
Other | (5,292) | (4,991) |
Gross deferred tax liabilities | (17,564) | (19,680) |
Net deferred tax assets | $ 23,168 | $ 20,651 |
Income Taxes - Classification o
Income Taxes - Classification of Net Deferred Tax Asset (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Income Tax Disclosure [Abstract] | ||
Long-term deferred tax assets | $ 30,392 | $ 29,149 |
Long-term deferred tax liabilities | (7,224) | (8,498) |
Net deferred tax assets | $ 23,168 | $ 20,651 |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Operating Loss Carryforwards [Line Items] | |||
Unremitted earnings of foreign subsidiaries | $ 27,211,000 | ||
Unrecognized tax benefits that would impact effective tax rate | 2,545,000 | $ 2,545,000 | |
Expense related to interest and penalties | 0 | $ 0 | $ 0 |
State and Local Jurisdiction | |||
Operating Loss Carryforwards [Line Items] | |||
Net operating loss carry forwards | 39,638,000 | ||
General business and foreign tax credit carry forwards | 1,054,000 | ||
Foreign Tax Authority | |||
Operating Loss Carryforwards [Line Items] | |||
Net operating loss carry forwards | 77,027,000 | ||
General business and foreign tax credit carry forwards | 714,000 | ||
Domestic Tax Authority | |||
Operating Loss Carryforwards [Line Items] | |||
General business and foreign tax credit carry forwards | $ 20,422,000 |
Income Taxes - Schedule of Inco
Income Taxes - Schedule of Income Tax Contingencies (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | |||
Balance as of January 1 | $ 2,545 | $ 2,891 | $ 3,449 |
Tax positions related to the current year: | |||
Additions | 0 | 0 | 0 |
Tax positions related to the prior years: | |||
Reductions | 0 | 0 | 0 |
Expirations of statutes of limitation | 0 | (346) | (558) |
Balance as of December 31 | $ 2,545 | $ 2,545 | $ 2,891 |
Leases - Narrative (Details)
Leases - Narrative (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Leases [Abstract] | |||
Option to extend | true | ||
Option to terminate | true | ||
Operating Lease Income Comprehensive Income Extensible List Not Disclosed Flag | consolidated statements of operations | consolidated statements of operations | |
Operating lease income | $ 602 | ||
Variable lease income | $ 199 |
Leases - Schedule of Components
Leases - Schedule of Components of Lease Expense (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Lease Cost | ||
Operating lease cost | $ 4,532 | $ 4,736 |
Short-term lease cost | 675 | 958 |
Variable lease cost | 706 | 585 |
Total lease cost | $ 5,913 | $ 6,279 |
Leases -Schedule of Balance She
Leases -Schedule of Balance Sheet Information (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
ASSETS | ||
Operating lease right-of-use asset | $ 10,795 | $ 13,762 |
Liabilities: | ||
Operating lease current liability, included in other current liabilities | $ 3,871 | $ 3,938 |
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] | Accrued expenses and other current liabilities | Accrued expenses and other current liabilities |
Operating lease long-term liability | $ 7,684 | $ 10,594 |
Total leased liabilities | $ 11,555 | $ 14,532 |
Leases - Schedule of Maturities
Leases - Schedule of Maturities of Operating Lease Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] | ||
2024 | $ 4,220 | |
2025 | 3,488 | |
2026 | 2,134 | |
2027 | 1,060 | |
2028 | 1,065 | |
Thereafter | 992 | |
Total future minimum lease payments | 12,959 | |
Less: imputed interest | (1,404) | |
Total lease liabilities | $ 11,555 | $ 14,532 |
Leases - Schedule of Weighted-A
Leases - Schedule of Weighted-Average Remaining Lease Term and Discount Rate (Details) | Dec. 31, 2023 | Dec. 31, 2022 |
Leases [Abstract] | ||
Weighted-average remaining lease term (in years) | 4 years | 4 years 7 months 20 days |
Weighted-average discount rate | 5.98% | 5.67% |
Leases - Schedule of Other Info
Leases - Schedule of Other Information Related to Leases (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Operating cash flows: | ||
Cash paid related to operating lease obligations | $ 4,545 | $ 4,649 |
Non-cash activity: | ||
Right-of-use assets obtained in exchange for operating lease liabilities | $ 250 | $ 594 |
Share-Based Compensation Plan_2
Share-Based Compensation Plans - Narrative (Details) - USD ($) | 1 Months Ended | 12 Months Ended | 31 Months Ended | |||||||
May 31, 2022 | May 31, 2018 | May 31, 2016 | May 31, 2013 | Apr. 30, 2005 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | May 31, 2020 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Share-based compensation vested in period, fair value | $ 5,623,000 | $ 3,334,000 | $ 9,637,000 | |||||||
Excess tax benefit realized from vesting of restricted common shares | $ 230,000 | $ 543,000 | $ (563,000) | |||||||
Time-based awards | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Weighted average grant date fair value, granted (in dollars per share) | $ 18.48 | $ 18.71 | $ 35.13 | |||||||
Unrecognized compensation expense | $ 2,066,000 | |||||||||
Employee service share-based compensation, nonvested, period for recognition | 1 year 1 month 24 days | |||||||||
Performance-based awards | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Weighted average grant date fair value, granted (in dollars per share) | $ 17.08 | $ 20.64 | ||||||||
Unrecognized compensation expense | $ 0 | |||||||||
Phantom Share Units (PSUs) | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Volume-weighted average closing price of stock triggering settlement, period prior to vesting period | 30 days | |||||||||
Deferred compensation arrangement with individual, recorded liability | $ 795,000 | |||||||||
2016 Plan | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Share-based compensation award reserved for issuance of common shares (in shares) | 1,800,000 | 2,900,000 | ||||||||
Share-based compensation, increase in awards reserved for issuance of common shares (in shares) | 1,100,000 | |||||||||
Share-based compensation award granted in period (in shares) | 3,351,074 | |||||||||
Share-based compensation award, number of shares available for grant (in shares) | 1,173,002 | |||||||||
2016 Plan | Time-based awards | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Share-based compensation award granted in period (in shares) | 1,378,385 | |||||||||
Share-based compensation award vesting period | 3 years | 3 years | 3 years | |||||||
2016 Plan | Performance-based awards | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Share-based compensation award granted in period (in shares) | 1,972,689 | |||||||||
Share-based compensation award forfeited in period (in shares) | 1,624,076 | |||||||||
Share-based compensation award vesting period | 3 years | 3 years | 3 years | |||||||
Director Share Plan | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Share-based compensation award reserved for issuance of common shares (in shares) | 950,000 | 850,000 | 700,000 | 500,000 | ||||||
Share-based compensation, increase in awards reserved for issuance of common shares (in shares) | 100,000 | 150,000 | 200,000 | |||||||
Share-based compensation award vesting period | 1 year | |||||||||
Share-based compensation restricted common shares issued (in shares) | 866,716 | |||||||||
Share-based compensation, maximum number of shares issuable (in shares) | 83,284 |
Share-Based Compensation Plan_3
Share-Based Compensation Plans - Schedule of the Allocation of Performance Shares Between Total Shareholder Return and Earnings per Share (Details) - Performance-based awards | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Total shareholder return | 45% | 45% | 45% |
Earnings per share | 36% | 36% | 36% |
Return on invested capital | 18% | 18% | 18% |
Share-Based Compensation Plan_4
Share-Based Compensation Plans - Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) - $ / shares | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Time-based awards | |||
Share units | |||
Non-vested, beginning balance (in shares) | 570,803 | 450,331 | |
Granted (in shares) | 253,630 | 335,044 | |
Vested (in shares) | (264,566) | (168,222) | |
Forfeited or cancelled (in shares) | (149,151) | (46,350) | |
Non-vested, ending balance (in shares) | 410,716 | 570,803 | 450,331 |
Weighted- average grant date fair value | |||
Non-vested, beginning balance (in dollars per share) | $ 22.29 | $ 26.55 | |
Granted (in dollars per share) | 18.48 | 18.71 | $ 35.13 |
Vested (in dollars per share) | 20.88 | 27.12 | |
Forfeited or cancelled (in dollars per share) | 23.65 | 20.17 | |
Non-vested, ending balance (in dollars per share) | $ 20.35 | $ 22.29 | $ 26.55 |
Performance-based awards | |||
Share units | |||
Non-vested, beginning balance (in shares) | 767,592 | 578,985 | |
Granted (in shares) | 261,202 | 361,982 | |
Vested (in shares) | (6,289) | (2,317) | |
Forfeited or cancelled (in shares) | (603,556) | (171,058) | |
Non-vested, ending balance (in shares) | 418,949 | 767,592 | 578,985 |
Weighted- average grant date fair value | |||
Non-vested, beginning balance (in dollars per share) | $ 24.03 | $ 28.42 | |
Granted (in dollars per share) | 17.08 | 20.64 | |
Vested (in dollars per share) | 29.27 | 22.70 | |
Forfeited or cancelled (in dollars per share) | 22.45 | 31.75 | |
Non-vested, ending balance (in dollars per share) | $ 21.89 | $ 24.03 | $ 28.42 |
Employee Benefit Plans (Details
Employee Benefit Plans (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Retirement Benefits [Abstract] | |||
Expenses related to employee benefit plans | $ 5,536 | $ 4,883 | $ 5,082 |
Financial Instruments and Fai_3
Financial Instruments and Fair Value Measurements - Narrative (Details) | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||||
Apr. 30, 2022 USD ($) | Jun. 30, 2022 USD ($) | Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) contract | May 05, 2022 contract | Feb. 18, 2020 USD ($) | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||||||
Proceeds from settlement of net investment hedges | $ 0 | $ 3,820,000 | $ 0 | ||||
Total interest expense, net | (13,000,000) | (7,097,000) | (5,189,000) | ||||
Earn-out consideration obligation paid | $ (8,272,000) | ||||||
Earn-out consideration obligation paid within operating activities | 1,996,000 | ||||||
Earn-out consideration cash payment | 0 | 6,276,000 | $ 0 | ||||
Assets fair value adjustment | 0 | 0 | |||||
Net Investment Hedging | |||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||||||
Number of hedge contracts | contract | 2 | 2 | |||||
Net gain recorded on consolidated statement of operations | $ 3,716,000 | ||||||
Proceeds from settlement of net investment hedges | $ 3,820,000 | ||||||
Net Investment Hedging | Net Investment Hedge Due 2026 | |||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||||||
Notional amounts | $ 25,000,000 | ||||||
Net Investment Hedging | Net Investment Hedge Due 2028 | |||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||||||
Notional amounts | 25,000,000 | ||||||
Cash Flow Hedging | Mexican Peso-Denominated Foreign Currency Forward Contracts | |||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||||||
Notional amounts | 26,613,000 | 0 | |||||
Cash Flow Hedging | Interest rate swap | |||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||||||
Notional amounts | $ 50,000,000 | ||||||
Total interest expense, net | $ (290,000) | $ (156,000) | $ 651,000 |
Financial Instruments and Fai_4
Financial Instruments and Fair Value Measurements - Schedule of Derivative Instruments in Statement of Financial Position, Fair Value (Details) - Cash Flow Hedging - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 | Feb. 18, 2020 |
Interest rate swap | |||
Derivatives, Fair Value [Line Items] | |||
Notional amounts | $ 50,000 | ||
Designated as Hedging Instrument | Forward currency contracts | |||
Derivatives, Fair Value [Line Items] | |||
Notional amounts | $ 26,613 | $ 0 | |
Designated as Hedging Instrument | Forward currency contracts | Prepaid expenses and other current assets | |||
Derivatives, Fair Value [Line Items] | |||
Financial assets carried at fair value | 1,858 | 0 | |
Designated as Hedging Instrument | Interest rate swap | |||
Derivatives, Fair Value [Line Items] | |||
Notional amounts | 0 | 50,000 | |
Designated as Hedging Instrument | Interest rate swap | Prepaid expenses and other current assets | |||
Derivatives, Fair Value [Line Items] | |||
Financial assets carried at fair value | $ 0 | $ 294 |
Financial Instruments and Fai_5
Financial Instruments and Fair Value Measurements - Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Interest Expense | |||
Derivatives designated as cash flow hedges: | |||
Gain (loss) reclassified from other comprehensive income (loss) income into net (loss) income | $ 290 | $ 156 | $ (651) |
Designated as Hedging Instrument | Forward currency contracts | Cost of goods sold | |||
Derivatives designated as cash flow hedges: | |||
Gain (loss) reclassified from other comprehensive income (loss) income into net (loss) income | 337 | 1,572 | 341 |
Designated as Hedging Instrument | Forward currency contracts | Selling, general and administrative | |||
Derivatives designated as cash flow hedges: | |||
Gain (loss) reclassified from other comprehensive income (loss) income into net (loss) income | 109 | 504 | 107 |
Designated as Hedging Instrument | Cash Flow Hedging | Forward currency contracts | |||
Derivatives designated as cash flow hedges: | |||
Gain (loss) recorded in other comprehensive income (loss) | 2,304 | 1,346 | 923 |
Gain (loss) reclassified from other comprehensive income (loss) income into net (loss) income | 446 | 2,076 | 448 |
Designated as Hedging Instrument | Cash Flow Hedging | Interest rate swap | |||
Derivatives designated as cash flow hedges: | |||
Gain (loss) recorded in other comprehensive income (loss) | (4) | 953 | 164 |
Gain (loss) reclassified from other comprehensive income (loss) income into net (loss) income | 290 | 156 | (651) |
Designated as Hedging Instrument | Net Investment Hedging | Cross-currency swaps | |||
Derivatives designated as cash flow hedges: | |||
Gain (loss) recorded in other comprehensive income (loss) | 0 | 2,446 | 1,270 |
Gain (loss) reclassified from other comprehensive income (loss) income into net (loss) income | $ 0 | $ 0 | $ 0 |
Financial Instruments and Fai_6
Financial Instruments and Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - Fair Value, Recurring - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Financial assets carried at fair value: | ||
Forward currency contracts | $ 1,858 | $ 0 |
Interest rate swap | 0 | 294 |
Total financial assets carried at fair value | 1,858 | $ 294 |
Level 1 inputs | ||
Financial assets carried at fair value: | ||
Forward currency contracts | 0 | |
Interest rate swap | 0 | |
Total financial assets carried at fair value | 0 | |
Level 2 inputs | ||
Financial assets carried at fair value: | ||
Forward currency contracts | 1,858 | |
Interest rate swap | 0 | |
Total financial assets carried at fair value | 1,858 | |
Level 3 inputs | ||
Financial assets carried at fair value: | ||
Forward currency contracts | 0 | |
Interest rate swap | 0 | |
Total financial assets carried at fair value | $ 0 |
Financial Instruments and Fai_7
Financial Instruments and Fair Value Measurements - Summary of The Change in Fair Value of The Level 3 Financial Liabilities Related to Earn-Out Consideration (Details) - Earnout Consideration $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Balance at January 1 | $ 7,351 |
Change in fair value | 0 |
Foreign currency adjustments | 921 |
Earn-out consideration cash payment | (8,272) |
Balance at December 31 | $ 0 |
Commitments and Contingencies -
Commitments and Contingencies - Narrative (Details) R$ in Thousands, $ in Thousands | 12 Months Ended | ||||||
Aug. 12, 2020 USD ($) | Aug. 12, 2020 BRL (R$) | Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Dec. 31, 2023 BRL (R$) | Dec. 31, 2022 BRL (R$) | |
Short-term Debt [Line Items] | |||||||
Environmental remediation cost incurred | $ 125 | $ 0 | $ 407 | ||||
Environmental remediation accrued undiscounted liability | 143 | 246 | |||||
Accrued expenses and other current liabilities | |||||||
Short-term Debt [Line Items] | |||||||
Environmental remediation accrued undiscounted liability | 136 | 132 | |||||
Letter of Credit | |||||||
Short-term Debt [Line Items] | |||||||
Line of credit | 1,489 | ||||||
Stoneridge Brazil | Civil, labor and other tax contingencies | |||||||
Short-term Debt [Line Items] | |||||||
Loss contingency, estimate of possible loss | $ 8,609 | $ 9,165 | R$ 41681 | R$ 47820 | |||
Stoneridge Brazil | CADE Fine | |||||||
Short-term Debt [Line Items] | |||||||
Litigation amount | $ 1,651 | R$ 7995 |
Restructuring and Business Re_3
Restructuring and Business Realignment - Narrative (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Electronics | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring expense | $ 290 | $ 290 | |
PM Sensor Exit | Control Devices | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring expense | 0 | 2,360 | |
Canton Facility Restructuring Plan | Control Devices | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring expense | $ 0 | $ 13 | 13 |
Cost of goods sold | Electronics | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring expense | 37 | ||
Cost of goods sold | PM Sensor Exit | Control Devices | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring expense | 1,510 | ||
Selling, general and administrative | Electronics | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring expense | 210 | ||
Selling, general and administrative | PM Sensor Exit | Control Devices | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring expense | 642 | ||
Design and development | Electronics | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring expense | 43 | ||
Design and development | PM Sensor Exit | Control Devices | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring expense | 208 | ||
Design and development | Canton Facility Restructuring Plan | Control Devices | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring expense | $ 13 |
Restructuring and Business Re_4
Restructuring and Business Realignment - Schedule of Restructuring and Related Costs (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Control Devices | PM Sensor Exit | |||
Restructuring Reserve [Roll Forward] | |||
Restructuring Reserve, Beginning Balance | $ 0 | $ 35 | $ 0 |
Charge to expense | 0 | 2,360 | |
Utilization, Cash | (35) | (2,137) | |
Utilization, Non-Cash | 0 | (188) | |
Restructuring Reserve, Ending Balance | 0 | 35 | |
Control Devices | Canton Facility Restructuring Plan | |||
Restructuring Reserve [Roll Forward] | |||
Restructuring Reserve, Beginning Balance | 93 | 165 | |
Charge to expense | 0 | 13 | 13 |
Utilization, Cash | (93) | (85) | |
Utilization, Non-Cash | 0 | 0 | |
Restructuring Reserve, Ending Balance | 0 | 93 | 165 |
Electronics | |||
Restructuring Reserve [Roll Forward] | |||
Restructuring Reserve, Beginning Balance | 0 | 227 | |
Charge to expense | 290 | 290 | |
Utilization, Cash | (517) | ||
Utilization, Non-Cash | 0 | ||
Restructuring Reserve, Ending Balance | 0 | 227 | |
Fixed asset impairment and accelerated depreciation | Control Devices | PM Sensor Exit | |||
Restructuring Reserve [Roll Forward] | |||
Restructuring Reserve, Beginning Balance | 0 | 0 | |
Charge to expense | 188 | ||
Utilization, Cash | 0 | ||
Utilization, Non-Cash | (188) | ||
Restructuring Reserve, Ending Balance | 0 | ||
Employee termination benefits | Control Devices | PM Sensor Exit | |||
Restructuring Reserve [Roll Forward] | |||
Restructuring Reserve, Beginning Balance | 0 | 35 | 0 |
Charge to expense | 0 | 139 | |
Utilization, Cash | (35) | (104) | |
Utilization, Non-Cash | 0 | 0 | |
Restructuring Reserve, Ending Balance | 0 | 35 | |
Employee termination benefits | Control Devices | Canton Facility Restructuring Plan | |||
Restructuring Reserve [Roll Forward] | |||
Restructuring Reserve, Beginning Balance | 93 | 165 | |
Charge to expense | 0 | 0 | |
Utilization, Cash | (93) | (72) | |
Utilization, Non-Cash | 0 | 0 | |
Restructuring Reserve, Ending Balance | 0 | 93 | 165 |
Employee termination benefits | Electronics | |||
Restructuring Reserve [Roll Forward] | |||
Restructuring Reserve, Beginning Balance | 0 | 227 | |
Charge to expense | 50 | ||
Utilization, Cash | (277) | ||
Utilization, Non-Cash | 0 | ||
Restructuring Reserve, Ending Balance | 0 | 227 | |
Other related costs | Control Devices | PM Sensor Exit | |||
Restructuring Reserve [Roll Forward] | |||
Restructuring Reserve, Beginning Balance | 0 | 0 | 0 |
Charge to expense | 0 | 2,033 | |
Utilization, Cash | 0 | (2,033) | |
Utilization, Non-Cash | 0 | 0 | |
Restructuring Reserve, Ending Balance | 0 | 0 | |
Other related costs | Control Devices | Canton Facility Restructuring Plan | |||
Restructuring Reserve [Roll Forward] | |||
Restructuring Reserve, Beginning Balance | 0 | 0 | |
Charge to expense | 0 | 13 | |
Utilization, Cash | 0 | (13) | |
Utilization, Non-Cash | 0 | 0 | |
Restructuring Reserve, Ending Balance | 0 | 0 | 0 |
Other related costs | Electronics | |||
Restructuring Reserve [Roll Forward] | |||
Restructuring Reserve, Beginning Balance | $ 0 | 0 | |
Charge to expense | 240 | ||
Utilization, Cash | (240) | ||
Utilization, Non-Cash | 0 | ||
Restructuring Reserve, Ending Balance | $ 0 | $ 0 |
Restructuring and Business Re_5
Restructuring and Business Realignment - Realignment Charges Classified by Statement of Operations (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Restructuring Cost and Reserve [Line Items] | |||
Total business realignment charges | $ 4,510 | $ 288 | $ 1,392 |
Cost of goods sold | |||
Restructuring Cost and Reserve [Line Items] | |||
Total business realignment charges | $ 792 | $ 0 | $ 8 |
Restructuring, Incurred Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] | Cost of goods sold | Cost of goods sold | Cost of goods sold |
Selling, general and administrative | |||
Restructuring Cost and Reserve [Line Items] | |||
Total business realignment charges | $ 3,321 | $ 288 | $ 1,375 |
Restructuring, Incurred Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] | Selling, general and administrative | Selling, general and administrative | Selling, general and administrative |
Design and development | |||
Restructuring Cost and Reserve [Line Items] | |||
Total business realignment charges | $ 397 | $ 0 | $ 9 |
Restructuring, Incurred Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] | Design and development | Design and development | Design and development |
Control Devices | |||
Restructuring Cost and Reserve [Line Items] | |||
Total business realignment charges | $ 511 | $ 0 | $ 192 |
Control Devices | Cost of goods sold | |||
Restructuring Cost and Reserve [Line Items] | |||
Severance costs | 369 | ||
Control Devices | Selling, general and administrative | |||
Restructuring Cost and Reserve [Line Items] | |||
Severance costs | 142 | 192 | |
Electronics | |||
Restructuring Cost and Reserve [Line Items] | |||
Total business realignment charges | 2,862 | 0 | 3 |
Electronics | Cost of goods sold | |||
Restructuring Cost and Reserve [Line Items] | |||
Severance costs | 423 | 1 | |
Electronics | Selling, general and administrative | |||
Restructuring Cost and Reserve [Line Items] | |||
Severance costs | 2,057 | (7) | |
Electronics | Design and development | |||
Restructuring Cost and Reserve [Line Items] | |||
Severance costs | 382 | 9 | |
Stoneridge Brazil | |||
Restructuring Cost and Reserve [Line Items] | |||
Total business realignment charges | 0 | 98 | 59 |
Stoneridge Brazil | Cost of goods sold | |||
Restructuring Cost and Reserve [Line Items] | |||
Severance costs | 7 | ||
Stoneridge Brazil | Selling, general and administrative | |||
Restructuring Cost and Reserve [Line Items] | |||
Severance costs | 98 | 52 | |
Unallocated Corporate | |||
Restructuring Cost and Reserve [Line Items] | |||
Total business realignment charges | 1,137 | 190 | 1,138 |
Unallocated Corporate | Selling, general and administrative | |||
Restructuring Cost and Reserve [Line Items] | |||
Severance costs | 1,122 | $ 190 | $ 1,138 |
Unallocated Corporate | Design and development | |||
Restructuring Cost and Reserve [Line Items] | |||
Severance costs | $ 15 |
Segment Reporting - Narrative (
Segment Reporting - Narrative (Details) | 12 Months Ended |
Dec. 31, 2023 segment | |
Segment Reporting [Abstract] | |
Number of reportable segments | 3 |
Segment Reporting - Schedule of
Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Net Sales: | |||
Total net sales | $ 975,818 | $ 899,923 | $ 770,462 |
Operating Income (Loss): | |||
Total operating income | 12,836 | 2,935 | 15,411 |
Depreciation and Amortization: | |||
Total depreciation and amortization | 33,638 | 33,691 | 33,828 |
Interest Expense (Income), net: | |||
Total interest expense, net | 13,000 | 7,097 | 5,189 |
Capital Expenditures: | |||
Total capital expenditures | 31,826 | 27,232 | 22,949 |
Total Assets: | |||
Total assets | 679,900 | 652,105 | |
Eliminations | |||
Net Sales: | |||
Total net sales | (34,829) | (31,460) | (29,694) |
Total Assets: | |||
Total assets | (370,493) | (371,992) | |
Unallocated Corporate | |||
Operating Income (Loss): | |||
Total operating income | (32,509) | (29,260) | (28,015) |
Depreciation and Amortization: | |||
Total depreciation and amortization | 2,388 | 2,318 | 2,134 |
Interest Expense (Income), net: | |||
Total interest expense, net | 12,773 | 7,277 | 5,948 |
Capital Expenditures: | |||
Total capital expenditures | 1,229 | 653 | 1,142 |
Total Assets: | |||
Total assets | 419,469 | 419,469 | |
Control Devices | |||
Net Sales: | |||
Total net sales | 342,065 | 342,596 | 355,775 |
Control Devices | Inter-segment sales | |||
Net Sales: | |||
Total net sales | 3,195 | 2,719 | 3,502 |
Control Devices | Operating Segments | |||
Net Sales: | |||
Total net sales | 345,260 | 345,315 | 359,276 |
Operating Income (Loss): | |||
Total operating income | 13,582 | 23,917 | 54,933 |
Depreciation and Amortization: | |||
Total depreciation and amortization | 12,414 | 13,521 | 15,351 |
Interest Expense (Income), net: | |||
Total interest expense, net | 149 | 93 | 132 |
Capital Expenditures: | |||
Total capital expenditures | 9,230 | 12,620 | 9,154 |
Total Assets: | |||
Total assets | 159,612 | 174,535 | |
Electronics | |||
Net Sales: | |||
Total net sales | 576,539 | 505,097 | 357,910 |
Electronics | Inter-segment sales | |||
Net Sales: | |||
Total net sales | 31,621 | 28,709 | 26,192 |
Electronics | Operating Segments | |||
Net Sales: | |||
Total net sales | 608,160 | 533,806 | 384,103 |
Operating Income (Loss): | |||
Total operating income | 27,309 | 5,128 | (12,502) |
Depreciation and Amortization: | |||
Total depreciation and amortization | 14,035 | 13,913 | 12,487 |
Interest Expense (Income), net: | |||
Total interest expense, net | 1,771 | 1,009 | 462 |
Capital Expenditures: | |||
Total capital expenditures | 18,313 | 10,479 | 9,735 |
Total Assets: | |||
Total assets | 404,994 | 369,232 | |
Stoneridge Brazil | |||
Net Sales: | |||
Total net sales | 57,214 | 52,230 | 56,777 |
Stoneridge Brazil | Inter-segment sales | |||
Net Sales: | |||
Total net sales | 13 | 32 | 0 |
Stoneridge Brazil | Operating Segments | |||
Net Sales: | |||
Total net sales | 57,227 | 52,262 | 56,777 |
Operating Income (Loss): | |||
Total operating income | 4,454 | 3,150 | 995 |
Depreciation and Amortization: | |||
Total depreciation and amortization | 4,801 | 3,939 | 3,856 |
Interest Expense (Income), net: | |||
Total interest expense, net | (1,693) | (1,282) | (1,353) |
Capital Expenditures: | |||
Total capital expenditures | 3,054 | 3,480 | $ 2,918 |
Total Assets: | |||
Total assets | $ 66,318 | $ 60,861 |
Segment Reporting - Schedule _2
Segment Reporting - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Total net sales | $ 975,818 | $ 899,923 | $ 770,462 |
Long-term assets: | |||
Total long-term assets | 250,510 | 242,554 | |
North America | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Total net sales | 495,541 | 444,928 | 386,944 |
Long-term assets: | |||
Total long-term assets | 92,419 | 92,149 | |
South America | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Total net sales | 57,214 | 52,230 | 56,777 |
Long-term assets: | |||
Total long-term assets | 32,679 | 31,796 | |
Europe and Other | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Total net sales | 423,063 | 402,765 | $ 326,741 |
Long-term assets: | |||
Total long-term assets | $ 125,412 | $ 118,609 |
SCHEDULE II - VALUATION AND Q_2
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Accounts receivable reserves: | |||
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] | |||
Balance at beginning of period | $ 962 | $ 1,443 | $ 817 |
Charged to costs and expenses | 412 | 1,255 | 1,030 |
Write-offs | (316) | (1,736) | (404) |
Balance at end of period | 1,058 | 962 | 1,443 |
Valuation allowance for deferred tax assets: | |||
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] | |||
Balance at beginning of period | 18,496 | 14,516 | 10,237 |
Net additions charged to income (expense) | 1,865 | 4,975 | 4,768 |
Write-offs | 721 | (995) | (489) |
Balance at end of period | $ 21,082 | $ 18,496 | $ 14,516 |